{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 643, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:38:40Z", "timestamp": 1574368720784}, "reference-count": 0, "publisher": "BMJ", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Heart"], "DOI": "10.1136/hrt.2007.134684", "type": "journal-article", "created": {"date-parts": [[2008, 5, 9]], "date-time": "2008-05-09T00:34:47Z", "timestamp": 1210293287000}, "page": "1478-1484", "source": "Crossref", "is-referenced-by-count": 115, "title": ["Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes"], "prefix": "10.1136", "volume": "94", "author": [{"given": "J P", "family": "Kaski", "sequence": "first", "affiliation": []}, {"given": "P", "family": "Syrris", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Burch", "sequence": "additional", "affiliation": []}, {"given": "M-T", "family": "Tome-Esteban", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Fenton", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Christiansen", "sequence": "additional", "affiliation": []}, {"given": "P S", "family": "Andersen", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Sebire", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Ashworth", "sequence": "additional", "affiliation": []}, {"given": "J E", "family": "Deanfield", "sequence": "additional", "affiliation": []}, {"given": "W J", "family": "McKenna", "sequence": "additional", "affiliation": []}, {"given": "P M", "family": "Elliott", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2008, 7, 31]]}, "container-title": ["Heart"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/hrt.2007.134684", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T22:23:59Z", "timestamp": 1482531839000}, "score": 54.99841, "issued": {"date-parts": [[2008, 7, 31]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2008, 7, 31]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1136/hrt.2007.134684", "ISSN": ["1355-6037"], "issn-type": [{"value": "1355-6037", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:21:36Z", "timestamp": 1574328096489}, "reference-count": 5, "publisher": "Cambridge University Press (CUP)", "issue": "06", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CTY"], "published-print": {"date-parts": [[2007, 12]]}, "DOI": "10.1017/s1047951107001291", "type": "journal-article", "created": {"date-parts": [[2007, 11, 1]], "date-time": "2007-11-01T11:10:34Z", "timestamp": 1193915434000}, "source": "Crossref", "is-referenced-by-count": 14, "title": ["Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood"], "prefix": "10.1017", "volume": "17", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}, {"given": "Michael", "family": "Burch", "sequence": "additional", "affiliation": []}, {"given": "Perry M.", "family": "Elliott", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2007, 11, 1]]}, "reference": [{"key": "S1047951107001291_ref3", "DOI": "10.1016/j.jacc.2004.08.027", "doi-asserted-by": "publisher"}, {"key": "S1047951107001291_ref2", "DOI": "10.1056/NEJM200012073432304", "doi-asserted-by": "publisher"}, {"key": "S1047951107001291_ref4", "DOI": "10.1097/00019606-200212000-00004", "doi-asserted-by": "publisher"}, {"key": "S1047951107001291_ref5", "DOI": "10.1016/0140-6736(93)92930-R", "doi-asserted-by": "publisher"}, {"key": "S1047951107001291_ref1", "DOI": "10.1016/j.healun.2004.06.011", "doi-asserted-by": "publisher"}], "container-title": ["Cardiology in the Young"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1047951107001291", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 23]], "date-time": "2017-04-23T02:38:30Z", "timestamp": 1492915110000}, "score": 34.869797, "issued": {"date-parts": [[2007, 11, 1]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2007, 12]]}, "issue": "06"}, "alternative-id": ["S1047951107001291"], "URL": "http://dx.doi.org/10.1017/s1047951107001291", "relation": {"cites": []}, "ISSN": ["1047-9511", "1467-1107"], "issn-type": [{"value": "1047-9511", "type": "print"}, {"value": "1467-1107", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:56:33Z", "timestamp": 1574312193493}, "reference-count": 26, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": ["ahajournals.org"], "crossmark-restriction": true}, "short-container-title": ["Circ Cardiovasc Genet"], "published-print": {"date-parts": [[2009, 10]]}, "DOI": "10.1161/circgenetics.108.821314", "type": "journal-article", "created": {"date-parts": [[2009, 7, 17]], "date-time": "2009-07-17T01:37:56Z", "timestamp": 1247794676000}, "page": "436-441", "update-policy": "http://dx.doi.org/10.1161/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 90, "title": ["Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy"], "prefix": "10.1161", "volume": "2", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "Petros", "family": "Syrris", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "Maria Teresa Tome", "family": "Esteban", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "Sharon", "family": "Jenkins", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "Antonios", "family": "Pantazis", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "John E.", "family": "Deanfield", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "William J.", "family": "McKenna", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}, {"given": "Perry M.", "family": "Elliott", "sequence": "additional", "affiliation": [{"name": "From the Inherited Cardiovascular Diseases Unit (J.P.K., J.E.D.), Institute of Child Health, University College London; Department of Medicine (P.S., W.J.M., P.M.E.), University College London; Great Ormond Street Hospital (J.P.K., M.T.T.E.); and The Heart Hospital (M.T.T.E., S.J., A.P., W.J.M., P.M.E.), University College London Hospitals, London, United Kingdom."}]}], "member": "276", "reference": [{"key": "e_1_3_2_1_2", "DOI": "10.1093/eurheartj/ehm342", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_2_2", "DOI": "10.1146/annurev.genom.6.080604.162132", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_3_2", "DOI": "10.1006/jmcc.2001.1340", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_4_2", "DOI": "10.1161/circ.105.4.446", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_5_2", "DOI": "10.1161/01.cir.0000066323.15244.54", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_6_2", "DOI": "10.1016/S0092-8674(01)00242-2", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_7_2", "DOI": "10.1161/circulationaha.106.621185", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_8_2", "DOI": "10.1161/circulationaha.104.530303", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_9_2", "DOI": "10.1161/circ.94.8.2021", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_10_2", "DOI": "10.1056/NEJM198609043151003", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_11_2", "DOI": "10.1016/j.pcl.2004.04.017", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_12_2", "DOI": "10.1161/circ.93.5.841", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_13_2", "DOI": "10.1136/hrt.2007.126748", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_14_2", "volume": "47", "first-page": "260", "year": "1992", "journal-title": "Cesk Pediatr"}, {"key": "e_1_3_2_15_2", "DOI": "10.1016/S0968-0004(99)01540-6", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_16_2", "DOI": "10.1056/NEJMoa075463", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_17_2", "volume": "24", "first-page": "2003", "journal-title": "Eur Heart J"}, {"key": "e_1_3_2_18_2", "DOI": "10.1152/ajpheart.00650.2004", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_19_2", "DOI": "10.1007/s004390050695", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_20_2", "DOI": "10.1006/jmcc.2000.1193", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_21_2", "volume": "36", "first-page": "542", "year": "1999", "journal-title": "J Med Genet"}, {"key": "e_1_3_2_22_2", "DOI": "10.1006/bbrc.1999.1221", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_23_2", "DOI": "10.1161/01.res.0000263008.66799.aa", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_24_2", "DOI": "10.1056/NEJMoa033349", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_25_2", "DOI": "10.1161/circulationaha.105.546481", "doi-asserted-by": "publisher"}, {"key": "e_1_3_2_26_2", "DOI": "10.1086/340847", "doi-asserted-by": "publisher"}], "container-title": ["Circulation: Cardiovascular Genetics"], "language": "en", "deposited": {"date-parts": [[2019, 1, 8]], "date-time": "2019-01-08T11:23:25Z", "timestamp": 1546946605000}, "score": 30.750523, "issued": {"date-parts": [[2009, 10]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2009, 10]]}, "issue": "5"}, "alternative-id": ["10.1161/CIRCGENETICS.108.821314"], "URL": "http://dx.doi.org/10.1161/circgenetics.108.821314", "relation": {"cites": []}, "ISSN": ["1942-325X", "1942-3268"], "issn-type": [{"value": "1942-325X", "type": "print"}, {"value": "1942-3268", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:43:53Z", "timestamp": 1574430233595}, "reference-count": 38, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Circ Cardiovasc Genet"], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1161/circgenetics.111.959973", "type": "journal-article", "created": {"date-parts": [[2011, 12, 6]], "date-time": "2011-12-06T05:23:06Z", "timestamp": 1323148986000}, "page": "10-17", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene"], "prefix": "10.1161", "volume": "5", "author": [{"given": "Ferdinando", "family": "Pasquale", "sequence": "first", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}, {"given": "Petros", "family": "Syrris", "sequence": "additional", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}, {"given": "Juan Pablo", "family": "Kaski", "sequence": "additional", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}, {"given": "Jens", "family": "Mogensen", "sequence": "additional", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}, {"given": "William J.", "family": "McKenna", "sequence": "additional", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}, {"given": "Perry", "family": "Elliott", "sequence": "additional", "affiliation": [{"name": "From the Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom (F.P., W.J.M., P.E.); Istituto di Cardiologia Ospedale S.Orsola Malpighi, Bologna, Italy (F.P.); Institute of Cardiovascular Science, University College London, London, United Kingdom (P.S.); Great Ormond Street Hospital for Children, London, United Kingdom (J.P.K.); and Skejby University Hospital, \u00c5arhus, Denmark (J.M.)."}]}], "member": "276", "reference": [{"key": "e_1_3_3_2_2", "DOI": "10.1161/circ.92.4.785", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_3_2", "DOI": "10.1056/NEJM198703263161305", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_4_2", "DOI": "10.1001/jama.1996.03540030033028", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_5_2", "DOI": "10.1001/jama.296.13.1593", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_6_2", "DOI": "10.1016/0002-9149(87)90998-2", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_7_2", "DOI": "10.1016/j.jacc.2005.04.062", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_8_2", "DOI": "10.1161/circ.98.14.1460", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_9_2", "DOI": "10.1016/S0735-1097(02)01900-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_10_2", "DOI": "10.1136/hrt.82.5.621", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_11_2", "DOI": "10.1136/hrt.2005.068577", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_12_2", "DOI": "10.1016/S0092-8674(01)00242-2", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_13_2", "DOI": "10.1056/NEJM199204233261703", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_14_2", "DOI": "10.1161/circ.97.22.2230", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_15_2", "DOI": "10.1161/01.cir.0000042675.59901.14", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_16_2", "DOI": "10.1053/eupc.1999.0067", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_17_2", "DOI": "10.1056/NEJM199504203321603", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_18_2", "DOI": "10.1016/S0735-1097(02)01900-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_19_2", "DOI": "10.1016/S0735-1097(96)00530-X", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_20_2", "DOI": "10.1056/NEJM200006153422403", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_21_2", "DOI": "10.1136/hrt.82.5.621", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_22_2", "DOI": "10.1016/S0735-1097(03)00827-1", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_23_2", "DOI": "10.1016/0002-8703(68)90035-5", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_24_2", "DOI": "10.1053/euhj.2000.2399", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_25_2", "DOI": "10.1056/NEJM198609043151003", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_26_2", "DOI": "10.1016/S0735-1097(83)80269-1", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_27_2", "DOI": "10.1136/hrt.77.2.130", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_28_2", "DOI": "10.1161/circ.96.9.2987", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_29_2", "DOI": "10.1016/S0735-1097(03)00941-0", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_30_2", "DOI": "10.1136/jmg.40.5.e59", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_31_2", "DOI": "10.1016/j.jacc.2004.08.027", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_32_2", "DOI": "10.1161/circ.94.12.3069", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_33_2", "DOI": "10.1006/jmcc.1996.0322", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_34_2", "DOI": "10.1016/S0025-6196(11)61527-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_35_2", "DOI": "10.1136/hrt.2005.068577", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_36_2", "DOI": "10.1161/circ.98.5.391", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_37_2", "DOI": "10.1016/j.amjcard.2003.08.031", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_38_2", "DOI": "10.1093/eurheartj/ehp539", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_39_2", "DOI": "10.1161/01.cir.0000066323.15244.54", "doi-asserted-by": "publisher"}], "container-title": ["Circulation: Cardiovascular Genetics"], "language": "en", "deposited": {"date-parts": [[2019, 1, 8]], "date-time": "2019-01-08T15:33:12Z", "timestamp": 1546961592000}, "score": 27.072712, "issued": {"date-parts": [[2012, 2]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2012, 2]]}, "issue": "1"}, "alternative-id": ["10.1161/CIRCGENETICS.111.959973"], "URL": "http://dx.doi.org/10.1161/circgenetics.111.959973", "relation": {"cites": []}, "ISSN": ["1942-325X", "1942-3268"], "issn-type": [{"value": "1942-325X", "type": "print"}, {"value": "1942-3268", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T00:59:52Z", "timestamp": 1575334792549}, "reference-count": 0, "publisher": "PAGEPress Publications", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/4.0", "start": {"date-parts": [[2018, 1, 29]], "date-time": "2018-01-29T00:00:00Z", "timestamp": 1517184000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cardiogenetics"], "abstract": "<jats:p>Hypertrophic cardiomyopathy (HCM) is defined as left ventricular hypertrophy in the absence of loading conditions sufficient to cause the observed abnormality. The true prevalence in childhood is unknown; the aetiology is more heterogeneous than that seen in adult populations, and includes inborn errors of metabolism, malformation syndromes and neuromuscular syndromes. However, one of the greatest clinical challenges in managing young patients with HCM is identifying those at greatest risk of sudden cardiac death.</jats:p>", "DOI": "10.4081/cardiogenetics.2018.7201", "type": "journal-article", "created": {"date-parts": [[2018, 7, 12]], "date-time": "2018-07-12T12:01:14Z", "timestamp": 1531396874000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Risk of sudden cardiac death in childhood hypertrophic cardiomyopathy: Time to solve the mystery"], "prefix": "10.4081", "volume": "8", "author": [{"given": "Gabrielle", "family": "Norrish", "sequence": "first", "affiliation": []}, {"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "2549", "published-online": {"date-parts": [[2018, 1, 29]]}, "container-title": ["Cardiogenetics"], "link": [{"URL": "https://www.pagepressjournals.org/index.php/cardiogen/article/download/7201/6931", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.pagepressjournals.org/index.php/cardiogen/article/download/7201/6931", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T16:31:17Z", "timestamp": 1542817877000}, "score": 26.873417, "issued": {"date-parts": [[2018, 1, 29]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018, 1, 29]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4081/cardiogenetics.2018.7201", "ISSN": ["2035-8148", "2035-8253"], "issn-type": [{"value": "2035-8253", "type": "print"}, {"value": "2035-8148", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:11:21Z", "timestamp": 1574511081829}, "reference-count": 0, "publisher": "PAGEPress Publications", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cardiogenetics"], "DOI": "10.4081/cardiogenetics.2012.e10", "type": "journal-article", "created": {"date-parts": [[2012, 10, 19]], "date-time": "2012-10-19T18:03:20Z", "timestamp": 1350669800000}, "page": "10", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype"], "prefix": "10.4081", "volume": "2", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}, {"given": "Elena", "family": "Biagini", "sequence": "additional", "affiliation": []}, {"given": "Massimo", "family": "Lorenzini", "sequence": "additional", "affiliation": []}, {"given": "Claudio", "family": "Rapezzi", "sequence": "additional", "affiliation": []}, {"given": "Perry", "family": "Elliott", "sequence": "additional", "affiliation": []}], "member": "2549", "published-online": {"date-parts": [[2012, 10, 19]]}, "container-title": ["Cardiogenetics"], "link": [{"URL": "http://www.pagepressjournals.org/index.php/cardiogen/article/viewFile/594/pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 1, 13]], "date-time": "2015-01-13T14:02:59Z", "timestamp": 1421157779000}, "score": 26.289436, "issued": {"date-parts": [[2012, 10, 19]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 1, 4]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4081/cardiogenetics.2012.e10", "ISSN": ["2035-8148", "2035-8253"], "issn-type": [{"value": "2035-8253", "type": "print"}, {"value": "2035-8148", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T07:10:32Z", "timestamp": 1575443432500}, "reference-count": 5, "publisher": "Elsevier BV", "issue": "9919", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 3, 1]], "date-time": "2014-03-01T00:00:00Z", "timestamp": 1393632000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1016/s0140-6736(14)60400-1", "type": "journal-article", "created": {"date-parts": [[2014, 2, 28]], "date-time": "2014-02-28T00:30:44Z", "timestamp": 1393547444000}, "page": "781-782", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Cardiomyopathy in children: importance of aetiology in prognosis"], "prefix": "10.1016", "volume": "383", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}, {"given": "Giuseppe", "family": "Limongelli", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673614604001?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673614604001?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T09:26:59Z", "timestamp": 1538818019000}, "score": 25.979467, "issued": {"date-parts": [[2014, 3]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2014, 3]]}, "issue": "9919"}, "alternative-id": ["S0140673614604001"], "URL": "http://dx.doi.org/10.1016/s0140-6736(14)60400-1", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:32:37Z", "timestamp": 1575228757671}, "publisher-location": "Cham", "reference-count": 404, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319661124", "type": "print"}, {"value": "9783319661148", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-66114-8_9", "type": "book-chapter", "created": {"date-parts": [[2018, 1, 17]], "date-time": "2018-01-17T14:33:09Z", "timestamp": 1516199589000}, "page": "259-317", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies"], "prefix": "10.1007", "author": [{"given": "Mohammed Majid", "family": "Akhtar", "sequence": "first", "affiliation": []}, {"given": "Juan Pablo", "family": "Kaski", "sequence": "additional", "affiliation": []}, {"given": "Perry", "family": "Elliott", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 1, 18]]}, "reference": [{"key": "9_CR1", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1093/eurheartj/ehm342", "volume": "29", "author": "P Elliott", "year": "2008", "unstructured": "Elliott P, Anderson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270\u20136.", "journal-title": "Eur Heart J"}, {"key": "9_CR2", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1161/01.CIR.80.3.564", "volume": "80", "author": "MB Codd", "year": "1989", "unstructured": "Codd MB, Sugrue DD, Gersh BJ, Melton LJ 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989;80:564\u201372.", "journal-title": "Circulation"}, {"key": "9_CR3", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0002-9149(87)80107-8", "volume": "59", "author": "Y Hada", "year": "1987", "unstructured": "Hada Y, Sakamoto T, Amano K, Yamaguchi T, Takenaka K, Takahashi H, Takikawa R, Hasegawa I, Takahashi T, Suzuki J, et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. Am J Cardiol. 1987;59:183\u20134.", "journal-title": "Am J Cardiol"}, {"key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1016/0002-9149(94)90337-9", "volume": "73", "author": "BJ Maron", "year": "1994", "unstructured": "Maron BJ, Peterson EE, Maron MS, Peterson JE. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol. 1994;73:577\u201380.", "journal-title": "Am J Cardiol"}, {"key": "9_CR5", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1161/01.CIR.92.4.785", "volume": "92", "author": "BJ Maron", "year": "1995", "unstructured": "Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785\u20139.", "journal-title": "Circulation"}, {"key": "9_CR6", "doi-asserted-by": "crossref", "first-page": "2697", "DOI": "10.1161/CIRCULATIONAHA.105.593558", "volume": "113", "author": "H Morita", "year": "2006", "unstructured": "Morita H, Larson MG, Barr SC, Vasan RS, O'Donnell CJ, Hirschhorn JN, Levy D, Corey D, Seidman CE, Seidman JG, et al. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation. 2006;113:2697\u2013705.", "journal-title": "Circulation"}, {"key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1016/j.amjmed.2003.05.009", "volume": "116", "author": "Y Zou", "year": "2004", "unstructured": "Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, Lu S, Wu P, Zhang dagger Y, Shen dagger L, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med. 2004;116:14\u20138.", "journal-title": "Am J Med"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "1647", "DOI": "10.1056/NEJMoa021715", "volume": "348", "author": "SE Lipshultz", "year": "2003", "unstructured": "Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647\u201355.", "journal-title": "N Engl J Med"}, {"key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "1639", "DOI": "10.1056/NEJMoa021737", "volume": "348", "author": "AW Nugent", "year": "2003", "unstructured": "Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639\u201346.", "journal-title": "N Engl J Med"}, {"key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1006/jmcc.2001.1340", "volume": "33", "author": "AJ Marian", "year": "2001", "unstructured": "Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;33:655\u201370.", "journal-title": "J Mol Cell Cardiol"}, {"key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "2227", "DOI": "10.1161/01.CIR.0000066323.15244.54", "volume": "107", "author": "P Richard", "year": "2003", "unstructured": "Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227\u201332.", "journal-title": "Circulation"}, {"key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1016/S0092-8674(01)00242-2", "volume": "104", "author": "JG Seidman", "year": "2001", "unstructured": "Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557\u201367.", "journal-title": "Cell"}, {"key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "1881", "DOI": "10.1016/S0140-6736(04)16358-7", "volume": "363", "author": "P Elliott", "year": "2004", "unstructured": "Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881\u201391.", "journal-title": "Lancet"}, {"key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "3733", "DOI": "10.1093/eurheartj/ehu199", "volume": "35", "author": "RM Elliott", "year": "2014", "unstructured": "Elliott RM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35:3733\u20132779.", "journal-title": "Eur Heart J"}, {"key": "9_CR15", "doi-asserted-by": "crossref", "first-page": "1332", "DOI": "10.1161/CIRCULATIONAHA.104.530303", "volume": "112", "author": "AW Nugent", "year": "2005", "unstructured": "Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332\u20138.", "journal-title": "Circulation"}, {"issue": "19", "key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "1448", "DOI": "10.1093/eurheartj/ehs397", "volume": "34", "author": "C Rapezzi", "year": "2013", "unstructured": "Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Helio T, Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L, Elliott PM. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(19):1448\u201358.", "journal-title": "Eur Heart J"}, {"key": "9_CR17", "doi-asserted-by": "crossref", "first-page": "2021", "DOI": "10.1161/01.CIR.94.8.2021", "volume": "94", "author": "ML Schwartz", "year": "1996", "unstructured": "Schwartz ML, Cox GF, Lin AE, Korson MS, Perez-Atayde A, Lacro RV, Lipshultz SE. Clinical approach to genetic cardiomyopathy in children. Circulation. 1996;94:2021\u201338.", "journal-title": "Circulation"}, {"issue": "6", "key": "9_CR18", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1161/CIRCULATIONAHA.106.621185", "volume": "115", "author": "SD Colan", "year": "2007", "unstructured": "Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007;115(6):773\u201381.", "journal-title": "Circulation"}, {"key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1111/j.1365-2559.1995.tb00267.x", "volume": "26", "author": "MJ Davies", "year": "1995", "unstructured": "Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy\u2014pathology and pathogenesis. Histopathology. 1995;26:493\u2013500.", "journal-title": "Histopathology"}, {"key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1111/j.1365-2559.2004.01835.x", "volume": "44", "author": "SE Hughes", "year": "2004", "unstructured": "Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology. 2004;44:412\u201327.", "journal-title": "Histopathology"}, {"key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "1263", "DOI": "10.1016/S0002-9149(96)00180-4", "volume": "77", "author": "BJ Maron", "year": "1996", "unstructured": "Maron BJ, Hauser RG, Roberts WC. Hypertrophic cardiomyopathy with left ventricular apical diverticulum. Am J Cardiol. 1996;77:1263\u20135.", "journal-title": "Am J Cardiol"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "1838", "DOI": "10.1016/0002-9149(82)90200-4", "volume": "49", "author": "BJ Maron", "year": "1982", "unstructured": "Maron BJ, Bonow RO, Seshagiri TN, Roberts WC, Epstein SE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol. 1982;49:1838\u201348.", "journal-title": "Am J Cardiol"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1081/JCMR-120003956", "volume": "4", "author": "RT Sperling", "year": "2002", "unstructured": "Sperling RT, Parker JA, Manning WJ, Danias PG. Apical hypertrophic cardiomyopathy: clinical, electrocardiographic, scintigraphic, echocardiographic, and magnetic resonance imaging findings of a case. J Cardiovasc Magn Reson. 2002;4:291\u20135.", "journal-title": "J Cardiovasc Magn Reson"}, {"key": "9_CR24", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/0735-1097(90)90180-W", "volume": "15", "author": "JG Webb", "year": "1990", "unstructured": "Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol. 1990;15:83\u201390.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0033-0620(85)90024-6", "volume": "28", "author": "ED Wigle", "year": "1985", "unstructured": "Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1\u201383.", "journal-title": "Prog Cardiovasc Dis"}, {"issue": "7", "key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "622", "DOI": "10.1016/j.echo.2016.03.003", "volume": "29", "author": "JJ Silbiger", "year": "2016", "unstructured": "Silbiger JJ. Abnormalities of the mitral apparatus in hypertrophic cardiomyopathy: echocardiographic, pathophysiologic, and surgical insights. J Am Soc Echocardiogr. 2016;29(7):622\u201339.", "journal-title": "J Am Soc Echocardiogr"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "1651", "DOI": "10.1161/01.CIR.85.5.1651", "volume": "85", "author": "HG Klues", "year": "1992", "unstructured": "Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992;85:1651\u201360.", "journal-title": "Circulation"}, {"key": "9_CR28", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/0002-8703(83)90450-7", "volume": "106", "author": "H Kitazume", "year": "1983", "unstructured": "Kitazume H, Kramer JR, Krauthamer D, El Tobgi S, Proudfit WL, Sones FM. Myocardial bridges in obstructive hypertrophic cardiomyopathy. Am Heart J. 1983;106:131\u20135.", "journal-title": "Am Heart J"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1056/NEJM199810223391704", "volume": "339", "author": "AT Yetman", "year": "1998", "unstructured": "Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy\u2014a risk factor for sudden death. N Engl J Med. 1998;339:1201\u20139.", "journal-title": "N Engl J Med"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1016/S0735-1097(86)80181-4", "volume": "8", "author": "BJ Maron", "year": "1986", "unstructured": "Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545\u201357.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR31", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1136/heartjnl-2014-305645", "volume": "100", "author": "LR Lopes", "year": "2014", "unstructured": "Lopes LR, Elliott PM. A straightforward guide to the sarcomeric basis of cardiomyopathies. Heart. 2014;100:1916\u201323.", "journal-title": "Heart"}, {"key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1161/CIRCRESAHA.110.231670", "volume": "108", "author": "SP Harris", "year": "2011", "unstructured": "Harris SP, Lyons RG, Bezold KL, Robbins J, Seidman C, Watkins H. In the thick of it. HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res. 2011;108:751\u201364.", "journal-title": "Circ Res"}, {"key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/j.ymgme.2005.10.008", "volume": "88", "author": "JM Bos", "year": "2006", "unstructured": "Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab. 2006;88:78\u201385.", "journal-title": "Mol Genet Metab"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "1127", "DOI": "10.1016/j.jacc.2009.11.016", "volume": "55", "author": "C Chiu", "year": "2010", "unstructured": "Chiu C, Bagnall RD, Ingles J, Yeates L, Kennerson M, Donald JA, Jormakka M, Lind JM, Semsarian C. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J Am Coll Cardiol. 2010;55:1127\u201335.", "journal-title": "J Am Coll Cardiol"}, {"issue": "10", "key": "9_CR35", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1161/01.CIR.0000056522.82563.5F", "volume": "107", "author": "C Geier", "year": "2003", "unstructured": "Geier C, Perrot A, Ozcelik C, Binner P, Counsell D, Hoffmann K, Pilz B, Martiniak Y, Gehmlich K, van der Ven PF, Furst DO, Vornwald A, von Hodenberg E, Numberg P, Scheffold T, Dietz R, Osterziel KJ. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation. 2003;107(10):1390\u20135.", "journal-title": "Circulation"}, {"key": "9_CR36", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1161/01.RES.0000263008.66799.aa", "volume": "100", "author": "A Osio", "year": "2007", "unstructured": "Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2007;100:766\u20138.", "journal-title": "Circ Res"}, {"issue": "5", "key": "9_CR37", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1016/j.ajhg.2010.10.002", "volume": "87", "author": "H Wang", "year": "2010", "unstructured": "Wang H, Li Z, Wang J, Sun K, Cui Q, Song L, Zou Y, Wang X, Liu X, Hui R, Fan Y. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy. Am J Hum Genet. 2010;87(5):687\u201393.", "journal-title": "Am J Hum Genet"}, {"issue": "11", "key": "9_CR38", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1016/j.jacc.2009.12.016", "volume": "55", "author": "MJ Ackerman", "year": "2010", "unstructured": "Ackerman MJ, Bos JM. Z-Disc genes in Hypertrophic cardiomyopathy\u2014stretching the cardiomyopathies? JACC. 2010;55(11):1136\u20138.", "journal-title": "JACC"}, {"issue": "24", "key": "9_CR39", "doi-asserted-by": "crossref", "first-page": "1800", "DOI": "10.1136/heartjnl-2013-303939", "volume": "99", "author": "LR Lopes", "year": "2013", "unstructured": "Lopes LR, Rahman MS, Elliott PM. A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Heart. 2013;99(24):1800\u201311.", "journal-title": "Heart"}, {"issue": "4", "key": "9_CR40", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1136/jmedgenet-2012-101270", "volume": "50", "author": "LR Lopes", "year": "2013", "unstructured": "Lopes LR, Zekvati A, Syrris P, Hubank M, Giambartolomei C, Dalageorgou C, Jenkins S, McKenna W, Plagnol V, Elliott PM, UK10k Consortium. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet. 2013;50(4):228\u201339.", "journal-title": "J Med Genet"}, {"issue": "4", "key": "9_CR41", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1136/heartjnl-2014-306387", "volume": "101", "author": "LR Lopes", "year": "2015", "unstructured": "Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. 2015;101(4):294\u2013301.", "journal-title": "Heart"}, {"issue": "11", "key": "9_CR42", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/j.ejmg.2015.10.001", "volume": "58", "author": "LR Lopes", "year": "2015", "unstructured": "Lopes LR, Murphy C, Syrris P, Dalageorgou C, McKenna WJ, Elliott PM, Plagnol V. Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy. Eur J Med Genet. 2015;58(11):611\u20136.", "journal-title": "Eur J Med Genet"}, {"key": "9_CR43", "doi-asserted-by": "crossref", "first-page": "899", "DOI": "10.1016/j.yjmcc.2010.03.005", "volume": "48", "author": "Q Xu", "year": "2010", "unstructured": "Xu Q, Dewey S, Nguyen S, Gomes AV. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J Mol Cell Cardiol. 2010;48:899\u2013909.", "journal-title": "J Mol Cell Cardiol"}, {"key": "9_CR44", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1038/ng1295-438", "volume": "11", "author": "G Bonne", "year": "1995", "unstructured": "Bonne G, Carier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg H, Fiszman M, Komajda M, Schwarts K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438\u201340.", "journal-title": "Nat Genet"}, {"key": "9_CR45", "doi-asserted-by": "crossref", "first-page": "2499", "DOI": "10.1093/hmg/11.20.2499", "volume": "11", "author": "M Arad", "year": "2002", "unstructured": "Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet. 2002;11:2499\u2013506.", "journal-title": "Hum Mol Genet"}, {"key": "9_CR46", "doi-asserted-by": "crossref", "first-page": "2430", "DOI": "10.1161/CIRCULATIONAHA.110.978924", "volume": "122", "author": "CY Ho", "year": "2010", "unstructured": "Ho CY, Landstrom AP, Ackerman MJ. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation. 2010;122:2430\u201340.", "journal-title": "Circulation"}, {"key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1161/CIRCRESAHA.110.223834", "volume": "108", "author": "CE Seidman", "year": "2011", "unstructured": "Seidman CE, Seidman JG. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res. 2011;108:743\u201350.", "journal-title": "Circ Res"}, {"key": "9_CR48", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1093/cvr/cvp247", "volume": "85", "author": "L Carrier", "year": "2010", "unstructured": "Carrier L, Schlossarek S, Willis MS, Eschenhagen T. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res. 2010;85:330\u20138.", "journal-title": "Cardiovasc Res"}, {"issue": "3", "key": "9_CR49", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1161/CIRCRESAHA.109.202440", "volume": "105", "author": "S Marston", "year": "2009", "unstructured": "Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res. 2009;105(3):219\u201322.", "journal-title": "Circ Res"}, {"issue": "1", "key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/j.cardiores.2005.01.004", "volume": "66", "author": "A Sarikas", "year": "2005", "unstructured": "Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T, Zolk O. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res. 2005;66(1):33\u201344.", "journal-title": "Cardiovasc Res"}, {"issue": "11", "key": "9_CR51", "doi-asserted-by": "crossref", "first-page": "1473", "DOI": "10.1161/CIRCULATIONAHA.108.838672", "volume": "119", "author": "SJ Dijk Van", "year": "2009", "unstructured": "Van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation. 2009;119(11):1473\u201383.", "journal-title": "Circulation"}, {"key": "9_CR52", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1161/01.RES.85.9.841", "volume": "85", "author": "Q Yang", "year": "1999", "unstructured": "Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Circ Res. 1999;85:841\u20137.", "journal-title": "Circ Res"}, {"key": "9_CR53", "doi-asserted-by": "crossref", "first-page": "35846", "DOI": "10.1074/jbc.M606949200", "volume": "281", "author": "MV Razumova", "year": "2006", "unstructured": "Razumova MV, Shaffer JF, Tu AY, Flint GV, Regnier M, Harris SP. Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay: evidence for long-lived cross-bridges. J Biol Chem. 2006;281:35846\u201354.", "journal-title": "J Biol Chem"}, {"key": "9_CR54", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1016/S0008-6363(99)00213-8", "volume": "44", "author": "CS Redwood", "year": "1999", "unstructured": "Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20\u201336.", "journal-title": "Cardiovasc Res"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1161/01.RES.86.7.737", "volume": "86", "author": "MJ Tyska", "year": "2000", "unstructured": "Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res. 2000;86:737\u201344.", "journal-title": "Circ Res"}, {"key": "9_CR56", "doi-asserted-by": "crossref", "first-page": "1489", "DOI": "10.1006/jmcc.2000.1182", "volume": "32", "author": "W Bing", "year": "2000", "unstructured": "Bing W, Knott A, Redwood C, Esposito G, Purcell I, Watkins H, Marston S. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol. 2000;32:1489\u201398.", "journal-title": "J Mol Cell Cardiol"}, {"key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "14593", "DOI": "10.1021/bi0115232", "volume": "40", "author": "Y Deng", "year": "2001", "unstructured": "Deng Y, Schmidtmann A, Redlich A, Westerdorf B, Jaquet K, Thieleczek R. Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry. 2001;40:14593\u2013602.", "journal-title": "Biochemistry"}, {"key": "9_CR58", "doi-asserted-by": "crossref", "first-page": "22069", "DOI": "10.1074/jbc.M002502200", "volume": "275", "author": "K Elliott", "year": "2000", "unstructured": "Elliott K, Watkins H, Redwood CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem. 2000;275:22069\u201374.", "journal-title": "J Biol Chem"}, {"key": "9_CR59", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1093/oxfordjournals.jbchem.a022603", "volume": "127", "author": "K Harada", "year": "2000", "unstructured": "Harada K, Takahashi-Yanaga F, Minakami R, Morimoto S, Ohtsuki I. Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T. J Biochem. 2000;127:263\u20138.", "journal-title": "J Biochem"}, {"key": "9_CR60", "doi-asserted-by": "crossref", "first-page": "14488", "DOI": "10.1074/jbc.M309355200", "volume": "279", "author": "K Harada", "year": "2004", "unstructured": "Harada K, Potter JD. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J Biol Chem. 2004;279:14488\u201395.", "journal-title": "J Biol Chem"}, {"key": "9_CR61", "doi-asserted-by": "crossref", "first-page": "41742", "DOI": "10.1074/jbc.M303408200", "volume": "278", "author": "MJ Heller", "year": "2003", "unstructured": "Heller MJ, Nili M, Homsher E, Tobacman LS. Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility. J Biol Chem. 2003;278:41742\u20138.", "journal-title": "J Biol Chem"}, {"key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "5996", "DOI": "10.1021/bi036073n", "volume": "43", "author": "T Kobayashi", "year": "2004", "unstructured": "Kobayashi T, Dong WJ, Burkart EM, Cheung HC, Solaro RJ. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation. Biochemistry. 2004;43:5996\u20136004.", "journal-title": "Biochemistry"}, {"key": "9_CR63", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1152/physiolgenomics.00101.2002", "volume": "14", "author": "J Kohler", "year": "2003", "unstructured": "Kohler J, Chen Y, Brenner B, Gordon AM, Kraft T, Martyn DA, Regnier M, Rivera AJ, Wang CK, Chase PB. Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding. Physiol Genomics. 2003;14:117\u201328.", "journal-title": "Physiol Genomics"}, {"key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "11670", "DOI": "10.1074/jbc.M108912200", "volume": "277", "author": "R Lang", "year": "2002", "unstructured": "Lang R, Gomes AV, Zhao J, Housmans PR, Miller T, Potter JD. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem. 2002;277:11670\u20138.", "journal-title": "J Biol Chem"}, {"key": "9_CR65", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1038/70990", "volume": "5", "author": "DE Michele", "year": "1999", "unstructured": "Michele DE, Albayya FP, Metzger JM. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes. Nat Med. 1999;5:1413\u20137.", "journal-title": "Nat Med"}, {"key": "9_CR66", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1073/pnas.022628899", "volume": "99", "author": "S Morimoto", "year": "2002", "unstructured": "Morimoto S, Lu QW, Harada K, Takahashi-Yanaga F, Minakami R, Ohta M, Sasaguri T, Ohtsuki I. Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci U S A. 2002;99:913\u20138.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR67", "first-page": "H91", "volume": "287", "author": "BM Palmer", "year": "2004", "unstructured": "Palmer BM, Fishbaugher DE, Schmitt JP, Wang Y, Alpert NR, Seidman CE, Seidman JG, VanBuren P, Maughan DW. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol. 2004;287:H91\u20139.", "journal-title": "Am J Physiol"}, {"key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "1146", "DOI": "10.1161/01.RES.86.11.1146", "volume": "86", "author": "C Redwood", "year": "2000", "unstructured": "Redwood C, Lohmann K, Bing W, Esposito GM, Elliott K, Abdulrazzak H, Knott A, Purcell I, Marston S, Watkins H. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. Circ Res. 2000;86:1146\u201352.", "journal-title": "Circ Res"}, {"key": "9_CR69", "doi-asserted-by": "crossref", "first-page": "2440", "DOI": "10.1016/S0006-3495(03)75048-6", "volume": "84", "author": "O Roopnarine", "year": "2003", "unstructured": "Roopnarine O. Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy. Biophys J. 2003;84:2440\u20139.", "journal-title": "Biophys J"}, {"key": "9_CR70", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1074/jbc.275.1.624", "volume": "275", "author": "D Szczesna", "year": "2000", "unstructured": "Szczesna D, Zhang R, Zhao J, Jones M, Guzman G, Potter JD. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem. 2000;275:624\u201330.", "journal-title": "J Biol Chem"}, {"key": "9_CR71", "doi-asserted-by": "crossref", "first-page": "7086", "DOI": "10.1074/jbc.M009823200", "volume": "276", "author": "D Szczesna", "year": "2001", "unstructured": "Szczesna D, Ghosh D, Li Q, Gomes AV, Guzman G, Arana C, Zhi G, Stull JT, Potter JD. Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem. 2001;276:7086\u201392.", "journal-title": "J Biol Chem"}, {"key": "9_CR72", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1161/01.RES.0000034710.46739.C0", "volume": "91", "author": "MV Westfall", "year": "2002", "unstructured": "Westfall MV, Borton AR, Albayya FP, Metzger JM. Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants. Circ Res. 2002;91:525\u201331.", "journal-title": "Circ Res"}, {"key": "9_CR73", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1161/01.RES.84.4.475", "volume": "84", "author": "E Blanchard", "year": "1999", "unstructured": "Blanchard E, Seidman C, Seidman JG, LeWinter M, Maughan D. Altered crossbridge kinetics in the alpha MHC403/+ mouse model of familial hypertrophic cardiomyopathy. Circ Res. 1999;84:475\u201383.", "journal-title": "Circ Res"}, {"key": "9_CR74", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1023/A:1005678905119", "volume": "21", "author": "KA Palmiter", "year": "2000", "unstructured": "Palmiter KA, Tyska MJ, Haeberle JR, Alpert NR, Fananapazir L, Warshaw DM. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level. J Muscle Res Cell Motil. 2000;21:609\u201320.", "journal-title": "J Muscle Res Cell Motil"}, {"key": "9_CR75", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1161/01.RES.0000027530.58419.82", "volume": "91", "author": "DE Michele", "year": "2002", "unstructured": "Michele DE, Gomez CA, Hong KE, Westfall MV, Metzger JM. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade. Circ Res. 2002;91:255\u201362.", "journal-title": "Circ Res"}, {"key": "9_CR76", "doi-asserted-by": "crossref", "first-page": "3743", "DOI": "10.1074/jbc.M006746200", "volume": "276", "author": "T Miller", "year": "2001", "unstructured": "Miller T, Szczesna D, Housmans PR, Zhao J, de Freitas F, Gomes AV, Culbreath L, McCue J, Wang Y, Xu Y, et al. Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem. 2001;276:3743\u201355.", "journal-title": "J Biol Chem"}, {"key": "9_CR77", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1172/JCI4088", "volume": "102", "author": "L Oberst", "year": "1998", "unstructured": "Oberst L, Zhao G, Park JT, Brugada R, Michael LH, Entman ML, Roberts R, Marian AJ. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest. 1998;102:1498\u2013505.", "journal-title": "J Clin Invest"}, {"key": "9_CR78", "doi-asserted-by": "crossref", "first-page": "1815", "DOI": "10.1006/jmcc.2001.1445", "volume": "33", "author": "R Prabhakar", "year": "2001", "unstructured": "Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro JR, Wieczorek DF. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol. 2001;33:1815\u201328.", "journal-title": "J Mol Cell Cardiol"}, {"key": "9_CR79", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1023/A:1025409227350", "volume": "251", "author": "R Prabhakar", "year": "2003", "unstructured": "Prabhakar R, Petrashevskaya N, Schwartz A, Aronow B, Boivin GP, Molkentin JD, Wieczorek DF. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation. Mol Cell Biochem. 2003;251:33\u201342.", "journal-title": "Mol Cell Biochem"}, {"key": "9_CR80", "doi-asserted-by": "crossref", "first-page": "2800", "DOI": "10.1172/JCI2389", "volume": "101", "author": "JC Tardiff", "year": "1998", "unstructured": "Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J, Leinwand LA. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest. 1998;101:2800\u201311.", "journal-title": "J Clin Invest"}, {"key": "9_CR81", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1172/JCI6067", "volume": "104", "author": "JC Tardiff", "year": "1999", "unstructured": "Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, Leinwand LA. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest. 1999;104:469\u201381.", "journal-title": "J Clin Invest"}, {"issue": "16", "key": "9_CR82", "doi-asserted-by": "crossref", "first-page": "1058", "DOI": "10.1056/NEJM199504203321603", "volume": "332", "author": "H Watkins", "year": "1995", "unstructured": "Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332(16):1058\u201364.", "journal-title": "N Engl J Med"}, {"key": "9_CR83", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1161/01.RES.0000059562.91384.1A", "volume": "92", "author": "BC Knollmann", "year": "2003", "unstructured": "Knollmann BC, Kirchhof P, Sirenko SG, Degen H, Greene AE, Schober T, Mackow JC, Fabritz L, Potter JD, Morad M. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+\u2212dependent action potential remodeling. Circ Res. 2003;92:428\u201336.", "journal-title": "Circ Res"}, {"key": "9_CR84", "doi-asserted-by": "crossref", "first-page": "18097", "DOI": "10.1073/pnas.1012826107", "volume": "107", "author": "T Konno", "year": "2010", "unstructured": "Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M, Kawana M, Eminaga S, Gorham JN, Pandya K, Smithies O, Naya FJ, Olson EN, Seidman JG, Seidman CE. Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2010;107:18097\u2013102.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "10", "key": "9_CR85", "doi-asserted-by": "crossref", "first-page": "3520", "DOI": "10.1172/JCI42028", "volume": "120", "author": "P Teekakirikul", "year": "2010", "unstructured": "Teekakirikul P, Eminaga S, Toka O, Alcai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE, Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and required Tgf- \u00df. J Clin Invest. 2010;120(10):3520\u20139.", "journal-title": "J Clin Invest"}, {"key": "9_CR86", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1146/annurev.genom.6.080604.162132", "volume": "6", "author": "F Ahmad", "year": "2005", "unstructured": "Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodelling. Annu Rev Genomics Hum Genet. 2005;6:185\u2013216.", "journal-title": "Annu Rev Genomics Hum Genet"}, {"key": "9_CR87", "first-page": "H705", "volume": "280", "author": "M Chandra", "year": "2001", "unstructured": "Chandra M, Rundell VL, Tardiff JC, Leinwand LA, De Tombe PP, Solaro RJ. Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol. 2001;280:H705\u201313.", "journal-title": "Am J Physiol"}, {"key": "9_CR88", "doi-asserted-by": "crossref", "first-page": "1776", "DOI": "10.1016/S0735-1097(02)03009-7", "volume": "41", "author": "JG Crilley", "year": "2003", "unstructured": "Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol. 2003;41:1776\u201382.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR89", "doi-asserted-by": "crossref", "first-page": "1775", "DOI": "10.1172/JCI1940", "volume": "101", "author": "M Spindler", "year": "1998", "unstructured": "Spindler M, Saupe KW, Christe ME, Sweeney HL, Seidman CE, Seidman JG, Ingwall JS. Diastolic dysfunction and altered energetics in the alpha MHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest. 1998;101:1775\u201383.", "journal-title": "J Clin Invest"}, {"issue": "21", "key": "9_CR90", "doi-asserted-by": "crossref", "first-page": "2593", "DOI": "10.1093/eurheartj/ehp306", "volume": "30", "author": "M Michels", "year": "2009", "unstructured": "Michels M, Soliman OI, Phefferkom J, Hoedemaekers YM, Kofflard MJ, Dooijes D, Majoor-Krakauer D, Ten Cate FJ. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J. 2009;30(21):2593\u20138.", "journal-title": "Eur Heart J"}, {"key": "9_CR91", "first-page": "H1136", "volume": "280", "author": "MC Olsson", "year": "2001", "unstructured": "Olsson MC, Palmer BM, Leinwand LA, Moore RL. Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol. 2001;280:H1136\u201344.", "journal-title": "Am J Physiol"}, {"key": "9_CR92", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1161/CIRCULATIONAHA.105.583500", "volume": "114", "author": "KM Harris", "year": "2006", "unstructured": "Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216\u201325.", "journal-title": "Circulation"}, {"key": "9_CR93", "doi-asserted-by": "crossref", "first-page": "1808", "DOI": "10.1161/01.CIR.92.7.1808", "volume": "92", "author": "M Lechin", "year": "1995", "unstructured": "Lechin M, Quinones MA, Omran A, Hill R, Yu QT, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995;92:1808\u201312.", "journal-title": "Circulation"}, {"key": "9_CR94", "doi-asserted-by": "crossref", "first-page": "1085", "DOI": "10.1016/0140-6736(93)92064-Z", "volume": "342", "author": "AJ Marian", "year": "1993", "unstructured": "Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993;342:1085\u20136.", "journal-title": "Lancet"}, {"key": "9_CR95", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1161/CIRCULATIONAHA.111.090514", "volume": "127", "author": "MK Jensen", "year": "2013", "unstructured": "Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, Skovby F, Kober L, Bundgaard H. Penetrance of hypertrophic cardiomyopathy in children and adolescents. Circulation. 2013;127:48\u201354.", "journal-title": "Circulation"}, {"key": "9_CR96", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1056/NEJM198609043151003", "volume": "315", "author": "BJ Maron", "year": "1986", "unstructured": "Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610\u20134.", "journal-title": "N Engl J Med"}, {"key": "9_CR97", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1016/j.pcl.2004.04.017", "volume": "51", "author": "BJ Maron", "year": "2004", "unstructured": "Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am. 2004;51:1305\u201346.", "journal-title": "Pediatr Clin North Am"}, {"key": "9_CR98", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1161/CIRCGENETICS.108.821314", "volume": "2", "author": "JP Kaski", "year": "2009", "unstructured": "Kaski JP, Syrris P, Tome Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliot PM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009;2:436\u201341.", "journal-title": "Circ Cardiovasc Genet"}, {"key": "9_CR99", "doi-asserted-by": "crossref", "first-page": "1899", "DOI": "10.1056/NEJMoa075463", "volume": "358", "author": "H Morita", "year": "2008", "unstructured": "Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med. 2008;358:1899\u2013908.", "journal-title": "N Engl J Med"}, {"key": "9_CR100", "doi-asserted-by": "crossref", "first-page": "686", "DOI": "10.1161/01.CIR.84.2.686", "volume": "84", "author": "PJ Counihan", "year": "1991", "unstructured": "Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation. 1991;84:686\u201396.", "journal-title": "Circulation"}, {"key": "9_CR101", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.paed.2006.12.001", "volume": "17", "author": "MT Tome Esteban", "year": "2007", "unstructured": "Tome Esteban MT, Kaski JP. Hypertrophic cardiomyopathy in children. Paediatr Child Health. 2007;17:19\u201324.", "journal-title": "Paediatr Child Health"}, {"key": "9_CR102", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1017/S1047951102000306", "volume": "12", "author": "E Bruno", "year": "2002", "unstructured": "Bruno E, Maisuls H, Juaneda E, Moreyra E, Alday LE. Clinical features of hypertrophic cardiomyopathy in the young. Cardiol Young. 2002;12:147\u201352.", "journal-title": "Cardiol Young"}, {"key": "9_CR103", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1161/01.CIR.53.1.9", "volume": "53", "author": "BJ Maron", "year": "1976", "unstructured": "Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE. Asymetric septal hypertrophy in childhood. Circulation. 1976;53:9\u201319.", "journal-title": "Circulation"}, {"key": "9_CR104", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1161/01.CIR.65.1.7", "volume": "65", "author": "BJ Maron", "year": "1982", "unstructured": "Maron BJ, Tajik AJ, Ruttenberg HD, Graham TP, Atwood GF, Victorica BE, Lie JT, Roberts WC. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation. 1982;65:7\u201317.", "journal-title": "Circulation"}, {"key": "9_CR105", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/BF02076335", "volume": "4", "author": "MS Schaffer", "year": "1983", "unstructured": "Schaffer MS, Freedom RM, Rowe RD. Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients. Pediatr Cardiol. 1983;4:113\u20139.", "journal-title": "Pediatr Cardiol"}, {"key": "9_CR106", "first-page": "229", "volume": "77", "author": "JR Skinner", "year": "1997", "unstructured": "Skinner JR, Manzoor A, Hayes AM, Joffe HS, Martin RP. A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. Heart (British Cardiac Society). 1997;77:229\u201333.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR107", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1056/NEJMoa021332", "volume": "348", "author": "MS Maron", "year": "2003", "unstructured": "Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295\u2013303.", "journal-title": "N Engl J Med"}, {"key": "9_CR108", "doi-asserted-by": "crossref", "first-page": "650", "DOI": "10.1001/jama.281.7.650", "volume": "281", "author": "BJ Maron", "year": "1999", "unstructured": "Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281:650\u20135.", "journal-title": "JAMA"}, {"key": "9_CR109", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0002-8703(82)90654-8", "volume": "104", "author": "SD Beder", "year": "1982", "unstructured": "Beder SD, Gutgesell HP, Mullins CE, McNamara DG. Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child. Am Heart J. 1982;104:155\u20136.", "journal-title": "Am Heart J"}, {"key": "9_CR110", "doi-asserted-by": "crossref", "first-page": "1543", "DOI": "10.1016/j.jacc.2005.04.062", "volume": "46", "author": "E Biagini", "year": "2005", "unstructured": "Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, Lofiego C, Boriani G, Prandstraller D, Picchio FM, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol. 2005;46:1543\u201350.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR111", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/0167-5273(94)90286-0", "volume": "44", "author": "R Bingisser", "year": "1994", "unstructured": "Bingisser R, Candinas R, Schneider J, Hess OM. Risk factors for systolic dysfunction and ventricular dilatation in hypertrophic cardiomyopathy. Int J Cardiol. 1994;44:225\u201333.", "journal-title": "Int J Cardiol"}, {"key": "9_CR112", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/S0735-1097(87)80377-7", "volume": "9", "author": "S Fighali", "year": "1987", "unstructured": "Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol. 1987;9:288\u201394.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR113", "doi-asserted-by": "crossref", "first-page": "1210", "DOI": "10.1253/jcj.48.1210", "volume": "48", "author": "H Fujiwara", "year": "1984", "unstructured": "Fujiwara H, Onodera T, Tanaka M, Shirane H, Kato H, Yoshikawa J, Osakada G, Sasayama S, Kawai C. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J. 1984;48:1210\u20134.", "journal-title": "Jpn Circ J"}, {"key": "9_CR114", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1016/0735-1097(93)90054-5", "volume": "22", "author": "GM Hecht", "year": "1993", "unstructured": "Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:489\u201397.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR115", "doi-asserted-by": "crossref", "first-page": "1339", "DOI": "10.1016/S0002-9149(98)00164-7", "volume": "81", "author": "BJ Maron", "year": "1998", "unstructured": "Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:1339\u201344.", "journal-title": "Am J Cardiol"}, {"key": "9_CR116", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1136/hrt.74.5.508", "volume": "74", "author": "C Seiler", "year": "1995", "unstructured": "Seiler C, Jenni R, Vassalli G, Turina M, Hess OM. Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy. Br Heart J. 1995;74:508\u201316.", "journal-title": "Br Heart J"}, {"key": "9_CR117", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/0002-9149(87)90998-2", "volume": "60", "author": "P Spirito", "year": "1987", "unstructured": "Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987;60:123\u20139.", "journal-title": "Am J Cardiol"}, {"key": "9_CR118", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1016/0002-8703(79)90012-7", "volume": "97", "author": "FJ Cate ten", "year": "1979", "unstructured": "ten Cate FJ, Roelandt J. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J. 1979;97:762\u20135.", "journal-title": "Am Heart J"}, {"key": "9_CR119", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1016/j.jacc.2004.01.054", "volume": "44", "author": "R Thaman", "year": "2004", "unstructured": "Thaman R, Gimeno JR, Reith S, Esteban MT, Limongelli G, Murphy RT, Mist B, McKenna WJ, Elliott PM. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy. J Am Coll Cardiol. 2004;44:398\u2013405.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR120", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1136/hrt.2003.031161", "volume": "91", "author": "R Thaman", "year": "2005", "unstructured": "Thaman R, Gimeno JR, Murphy RT, Kubo T, Sachdev B, Mogensen J, Elliott PM, McKenna WJ. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart (British Cardiac Society). 2005;91:920\u20135.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR121", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1016/0002-8703(85)90561-7", "volume": "109", "author": "C Yutani", "year": "1985", "unstructured": "Yutani C, Imakita M, Ishibashi-Ueda H, Hatanaka K, Nagata S, Sakakibara H, Nimura Y. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J. 1985;109:545\u201353.", "journal-title": "Am Heart J"}, {"key": "9_CR122", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/S0735-1097(99)00630-0", "volume": "35", "author": "JN Cohn", "year": "2000", "unstructured": "Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569\u201382.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR123", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1136/heart.87.2.169", "volume": "87", "author": "WJ McKenna", "year": "2002", "unstructured": "McKenna WJ, Behr ER. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart (British Cardiac Society). 2002;87:169\u201376.", "journal-title": "Heart (British Cardiac Society)"}, {"issue": "4", "key": "9_CR124", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1136/heartjnl-2016-310138", "volume": "103", "author": "S Rosmini", "year": "2017", "unstructured": "Rosmini S, Biagini E, O'Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, McKenna WJ, Rapezzi C, Elliott PM. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy. Heart. 2017;103(4):300\u20136.", "journal-title": "Heart"}, {"key": "9_CR125", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1161/01.CIR.50.4.809", "volume": "50", "author": "BJ Maron", "year": "1974", "unstructured": "Maron BJ, Edwards JE, Henry WL, Clark CE, Bingle GJ, Epstein SE. Asymmetric septal hypertrophy (ASH) in infancy. Circulation. 1974;50:809\u201320.", "journal-title": "Circulation"}, {"key": "9_CR126", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1161/hc4601.097997", "volume": "104", "author": "I Olivotto", "year": "2001", "unstructured": "Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517\u201324.", "journal-title": "Circulation"}, {"key": "9_CR127", "doi-asserted-by": "crossref", "first-page": "1279", "DOI": "10.1016/S0735-1097(10)80014-2", "volume": "15", "author": "K Robinson", "year": "1990", "unstructured": "Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol. 1990;15:1279\u201385.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR128", "doi-asserted-by": "crossref", "first-page": "1217", "DOI": "10.1016/0002-9149(92)90939-V", "volume": "69", "author": "P Spirito", "year": "1992", "unstructured": "Spirito P, Lakatos E, Maron BJ. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol. 1992;69:1217\u201322.", "journal-title": "Am J Cardiol"}, {"issue": "6", "key": "9_CR129", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1136/heartjnl-2013-304276", "volume": "100", "author": "OP Guttmann", "year": "2014", "unstructured": "Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014;100(6):465\u201372.", "journal-title": "Heart"}, {"issue": "8", "key": "9_CR130", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.1002/ejhf.316", "volume": "17", "author": "OP Guttmann", "year": "2015", "unstructured": "Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM, Hypertrophic Cardiomyopathy Outcomes Investigators. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Jeart Fail. 2015;17(8):837\u201345.", "journal-title": "Eur J Jeart Fail"}, {"key": "9_CR131", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1016/0002-9149(79)90388-6", "volume": "44", "author": "H Yamaguchi", "year": "1979", "unstructured": "Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44:401\u201312.", "journal-title": "Am J Cardiol"}, {"key": "9_CR132", "doi-asserted-by": "crossref", "first-page": "1259", "DOI": "10.1161/01.CIR.80.5.1259", "volume": "80", "author": "L Fananapazir", "year": "1989", "unstructured": "Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, Maron BJ, Epstein SE. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation. 1989;80:1259\u201368.", "journal-title": "Circulation"}, {"key": "9_CR133", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1136/hrt.43.3.245", "volume": "43", "author": "DM Krikler", "year": "1980", "unstructured": "Krikler DM, Davies MJ, Rowland E, Goodwin JF, Evans RC, Shaw DB. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J. 1980;43:245\u201351.", "journal-title": "Br Heart J"}, {"issue": "9", "key": "9_CR134", "doi-asserted-by": "crossref", "first-page": "1403", "DOI": "10.1007/s10554-016-0915-z", "volume": "32", "author": "Y Bennani Smires", "year": "2016", "unstructured": "Bennani Smires Y, Victor G, Ribes D, Berry M, Cognet T, Mejean S, Huart A, Roussel M, Petermann A, Roncalli J, Carrie D, Rousseau H, Berry I, Chauveau D, Galinier M, Lairez O. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Int J Cardiovasc Imaging. 2016;32(9):1403\u201313.", "journal-title": "Int J Cardiovasc Imaging"}, {"key": "9_CR135", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/0002-9149(81)90604-4", "volume": "48", "author": "BJ Maron", "year": "1981", "unstructured": "Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981;48:252\u20137.", "journal-title": "Am J Cardiol"}, {"key": "9_CR136", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1136/hrt.46.2.168", "volume": "46", "author": "WJ McKenna", "year": "1981", "unstructured": "McKenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy: influence on prognosis. Br Heart J. 1981;46:168\u201372.", "journal-title": "Br Heart J"}, {"key": "9_CR137", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/0735-1097(88)90181-7", "volume": "11", "author": "WJ McKenna", "year": "1988", "unstructured": "McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;11:147\u201353.", "journal-title": "J Am Coll Cardiol"}, {"issue": "5", "key": "9_CR138", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1016/j.jacc.2004.11.043", "volume": "45", "author": "AS Adabag", "year": "2005", "unstructured": "Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;45(5):697\u2013704.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR139", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1136/hrt.61.2.178", "volume": "61", "author": "F Alfonso", "year": "1989", "unstructured": "Alfonso F, Frenneaux MP, McKenna WJ. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm. Br Heart J. 1989;61:178\u201381.", "journal-title": "Br Heart J"}, {"key": "9_CR140", "doi-asserted-by": "crossref", "first-page": "1699", "DOI": "10.1016/0735-1097(95)00390-8", "volume": "26", "author": "HG Klues", "year": "1995", "unstructured": "Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699\u2013708.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR141", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1016/0002-9149(81)90068-0", "volume": "48", "author": "BJ Maron", "year": "1981", "unstructured": "Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418\u201328.", "journal-title": "Am J Cardiol"}, {"key": "9_CR142", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1016/S0735-1097(83)80269-1", "volume": "2", "author": "LM Shapiro", "year": "1983", "unstructured": "Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1983;2:437\u201344.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR143", "doi-asserted-by": "crossref", "first-page": "2232", "DOI": "10.1161/CIRCULATIONAHA.106.644682", "volume": "114", "author": "MS Maron", "year": "2006", "unstructured": "Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232\u20139.", "journal-title": "Circulation"}, {"key": "9_CR144", "doi-asserted-by": "crossref", "first-page": "1288", "DOI": "10.1136/hrt.2007.126003", "volume": "94", "author": "JS Shah", "year": "2007", "unstructured": "Shah JS, Tome Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, Ward D, Kohli SK, Page SP, Demetrescu C, et al. Prevalence of exercise induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (British Cardiac Society). 2007;94:1288\u201394.", "journal-title": "Heart (British Cardiac Society)"}, {"issue": "23", "key": "9_CR145", "doi-asserted-by": "crossref", "first-page": "2346", "DOI": "10.1016/j.jacc.2011.02.033", "volume": "57", "author": "Y Minami", "year": "2011", "unstructured": "Minami Y, Kajimoto K, Terajima Y, Yashiro B, Okayama D, Haruki S, Nakajima T, Kawashiro N, Kawana M, Hagiwara N. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011;57(23):2346\u201355.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR146", "doi-asserted-by": "crossref", "first-page": "856", "DOI": "10.1016/S0735-1097(00)00818-4", "volume": "36", "author": "K Okeie", "year": "2000", "unstructured": "Okeie K, Shimizu M, Yoshio H, Ino H, Yamaguchi M, Matsuyama T, Yasuda T, Taki J, Mabuchi H. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36:856\u201363.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR147", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/0002-9149(93)90160-E", "volume": "72", "author": "P Perrone-Filardi", "year": "1993", "unstructured": "Perrone-Filardi P, Bacharach SL, Dilsizian V, Panza JA, Maurea S, Bonow RO. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Am J Cardiol. 1993;72:199\u2013204.", "journal-title": "Am J Cardiol"}, {"key": "9_CR148", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1016/S0894-7317(00)90021-X", "volume": "13", "author": "T Tabata", "year": "2000", "unstructured": "Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD. Subendocardial motion in hypertrophic cardiomyopathy: assessment from long- and short-axis views by pulsed tissue Doppler imaging. J Am Soc Echocardiogr. 2000;13:108\u201315.", "journal-title": "J Am Soc Echocardiogr"}, {"key": "9_CR149", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1136/heart.87.3.247", "volume": "87", "author": "Y Matsumura", "year": "2002", "unstructured": "Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart (British Cardiac Society). 2002;87:247\u201351.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR150", "doi-asserted-by": "crossref", "first-page": "1756", "DOI": "10.1161/01.CIR.0000124723.16433.31", "volume": "109", "author": "CJ McMahon", "year": "2004", "unstructured": "McMahon CJ, Nagueh SF, Pignatelli RH, Denfield SW, Dreyer WJ, Price JF, Clunie S, Bezold LI, Hays AL, Towbin JA, et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation. 2004;109:1756\u201362.", "journal-title": "Circulation"}, {"key": "9_CR151", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1161/01.CIR.104.2.128", "volume": "104", "author": "SF Nagueh", "year": "2001", "unstructured": "Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128\u201330.", "journal-title": "Circulation"}, {"key": "9_CR152", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1016/j.ahj.2005.12.005", "volume": "151", "author": "T Poutanen", "year": "2006", "unstructured": "Poutanen T, Tikanoja T, Jaaskelainen P, Jokinen E, Silvast A, Laakso M, Kuusisto J. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Am Heart J. 2006;151:725.", "journal-title": "Am Heart J"}, {"key": "9_CR153", "first-page": "60", "volume": "80", "author": "S Jones", "year": "1998", "unstructured": "Jones S, Elliott PM, Sharma S, McKenna WJ, Whipp BJ. Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society). 1998;80:60\u20137.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR154", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1016/S0002-9149(00)00854-7", "volume": "86", "author": "S Sharma", "year": "2000", "unstructured": "Sharma S, Elliott P, Whyte G, Jones S, Mahon N, Whipp B, McKenna WJ. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2000;86:162\u20138.", "journal-title": "Am J Cardiol"}, {"key": "9_CR155", "doi-asserted-by": "crossref", "first-page": "2044", "DOI": "10.1016/S0735-1097(99)00094-7", "volume": "33", "author": "I Olivotto", "year": "1999", "unstructured": "Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:2044\u201351.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR156", "doi-asserted-by": "crossref", "first-page": "2987", "DOI": "10.1161/01.CIR.96.9.2987", "volume": "96", "author": "N Sadoul", "year": "1997", "unstructured": "Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 1997;96:2987\u201391.", "journal-title": "Circulation"}, {"key": "9_CR157", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/S0735-1097(02)01950-2", "volume": "40", "author": "Q Ciampi", "year": "2002", "unstructured": "Ciampi Q, Betocchi S, Lombardi R, Manganelli F, Storto G, Losi MA, Pezzella E, Finizio F, Cuocolo A, Chiariello M. Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:278\u201384.", "journal-title": "J Am Coll Cardiol"}, {"issue": "6", "key": "9_CR158", "doi-asserted-by": "crossref", "first-page": "1022", "DOI": "10.1161/CIRCHEARTFAILURE.114.002248", "volume": "8", "author": "CJ Coats", "year": "2015", "unstructured": "Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, Elliott PM. Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy. Circ Heart Fail. 2015;8(6):1022\u201331.", "journal-title": "Circ Heart Fail"}, {"key": "9_CR159", "doi-asserted-by": "crossref", "first-page": "2156", "DOI": "10.1016/S0735-1097(02)02602-5", "volume": "40", "author": "L Choudhury", "year": "2002", "unstructured": "Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156\u201364.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR160", "doi-asserted-by": "crossref", "first-page": "1561", "DOI": "10.1016/S0735-1097(03)00189-X", "volume": "41", "author": "JC Moon", "year": "2003", "unstructured": "Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561\u20137.", "journal-title": "J Am Coll Cardiol"}, {"issue": "12", "key": "9_CR161", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1093/ehjci/jeu137", "volume": "15", "author": "T Gyllenhammar", "year": "2014", "unstructured": "Gyllenhammar T, Fernlund E, Jablonowski R, Jogi J, Engblom H, Liuba P, Arheden H, Carlsson M. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging. 2014;15(12):1350\u20137.", "journal-title": "Eur Heart J Cardiovasc Imaging"}, {"key": "9_CR162", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1186/s12968-014-0049-1", "volume": "16", "author": "TF Ismail", "year": "2014", "unstructured": "Ismail TF, Hsu LY, Greve AM, Goncalves C, Jabbour A, Gulati A, Hewins B, Mistry N, Wage R, Roughton M, Ferreira PF, Gatehouse P, Firmin D, O'Hanlon R, Pennell DJ, Prasad SK, Arai AE. Coronary microvascular ischemia in hypertrophic cardiomyopathy\u2014a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson. 2014;16:49.", "journal-title": "J Cardiovasc Magn Reson"}, {"key": "9_CR163", "doi-asserted-by": "crossref", "first-page": "1813", "DOI": "10.1016/S0735-1097(99)00421-0", "volume": "34", "author": "I Ostman-Smith", "year": "1999", "unstructured": "Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol. 1999;34:1813\u201322.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR164", "doi-asserted-by": "crossref", "first-page": "1252", "DOI": "10.1016/0002-9149(88)90269-X", "volume": "62", "author": "C Pollick", "year": "1988", "unstructured": "Pollick C. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Am J Cardiol. 1988;62:1252\u20135.", "journal-title": "Am J Cardiol"}, {"key": "9_CR165", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1016/0002-9149(88)90268-8", "volume": "62", "author": "C Pollick", "year": "1988", "unstructured": "Pollick C, Kimball B, Henderson M, Wigle ED. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol. 1988;62:1248\u201351.", "journal-title": "Am J Cardiol"}, {"key": "9_CR166", "doi-asserted-by": "crossref", "first-page": "1085", "DOI": "10.1016/0002-9149(88)90553-X", "volume": "62", "author": "M Sherrid", "year": "1988", "unstructured": "Sherrid M, Delia E, Dwyer E. Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 1988;62:1085\u20138.", "journal-title": "Am J Cardiol"}, {"key": "9_CR167", "doi-asserted-by": "crossref", "first-page": "1251", "DOI": "10.1016/j.jacc.2005.01.012", "volume": "45", "author": "MV Sherrid", "year": "2005", "unstructured": "Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;45:1251\u20138.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR168", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1161/01.CIR.72.4.853", "volume": "72", "author": "RO Bonow", "year": "1985", "unstructured": "Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation. 1985;72:853\u201364.", "journal-title": "Circulation"}, {"key": "9_CR169", "doi-asserted-by": "crossref", "first-page": "1052", "DOI": "10.1161/01.CIR.79.5.1052", "volume": "79", "author": "JE Udelson", "year": "1989", "unstructured": "Udelson JE, Bonow RO, O'Gara PT, Maron BJ, Van Lingen A, Bacharach SL, Epstein SE. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 1989;79:1052\u201360.", "journal-title": "Circulation"}, {"key": "9_CR170", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1161/01.CIR.64.3.437", "volume": "64", "author": "SE Epstein", "year": "1981", "unstructured": "Epstein SE, Rosing DR. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation. 1981;64:437\u201341.", "journal-title": "Circulation"}, {"key": "9_CR171", "doi-asserted-by": "crossref", "first-page": "1680", "DOI": "10.1161/01.CIR.92.7.1680", "volume": "92", "author": "ED Wigle", "year": "1995", "unstructured": "Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995;92:1680\u201392.", "journal-title": "Circulation"}, {"key": "9_CR172", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1161/01.CIR.52.1.88", "volume": "52", "author": "AG Morrow", "year": "1975", "unstructured": "Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation. 1975;52:88\u2013102.", "journal-title": "Circulation"}, {"key": "9_CR173", "doi-asserted-by": "crossref", "first-page": "470", "DOI": "10.1016/j.jacc.2005.02.090", "volume": "46", "author": "SR Ommen", "year": "2005", "unstructured": "Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470\u20136.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR174", "first-page": "709", "volume": "106", "author": "HD Schulte", "year": "1993", "unstructured": "Schulte HD, Bircks WH, Loesse B, Godehardt EA, Schwartzkopff B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg. 1993;106:709\u201317.", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "9_CR175", "doi-asserted-by": "crossref", "first-page": "1589", "DOI": "10.1016/S0022-5223(96)70018-1", "volume": "112", "author": "DA Theodoro", "year": "1996", "unstructured": "Theodoro DA, Danielson GK, Feldt RH, Anderson BJ. Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg. 1996;112:1589\u201397. discussion 1597\u20131589", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "9_CR176", "first-page": "V104", "volume": "76", "author": "WG Williams", "year": "1987", "unstructured": "Williams WG, Wigle ED, Rakowski H, Smallhorn J, LeBlanc J, Trusler GA. Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation. 1987;76:V104\u20138.", "journal-title": "Circulation"}, {"key": "9_CR177", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1016/S0735-1097(10)80176-7", "volume": "17", "author": "CH Seiler", "year": "1991", "unstructured": "Seiler CH, Hess OM, Schoenbeck M, et al. Long term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol. 1991;17:634\u201342.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR178", "doi-asserted-by": "crossref", "first-page": "2033", "DOI": "10.1161/01.CIR.0000162460.36735.71", "volume": "111", "author": "A Woo", "year": "2005", "unstructured": "Woo A, Williams WG, Choi R, et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation. 2005;111:2033\u201341.", "journal-title": "Circulation"}, {"key": "9_CR179", "doi-asserted-by": "crossref", "first-page": "2415", "DOI": "10.1161/01.CIR.98.22.2415", "volume": "98", "author": "L Faber", "year": "1998", "unstructured": "Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998;98:2415\u201321.", "journal-title": "Circulation"}, {"key": "9_CR180", "doi-asserted-by": "crossref", "first-page": "2075", "DOI": "10.1161/01.CIR.95.8.2075", "volume": "95", "author": "C Knight", "year": "1997", "unstructured": "Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997;95:2075\u201381.", "journal-title": "Circulation"}, {"key": "9_CR181", "doi-asserted-by": "crossref", "first-page": "852", "DOI": "10.1016/S0735-1097(00)00767-1", "volume": "36", "author": "NM Lakkis", "year": "2000", "unstructured": "Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH 3rd. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000;36:852\u20135.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR182", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1136/hrt.2009.173765", "volume": "96", "author": "SA Mohiddin", "year": "2010", "unstructured": "Mohiddin SA, Page S. Long-term benefits of pacing in obstructive hypertrophic cardiomyopathy. Heart. 2010;96:328\u201330.", "journal-title": "Heart"}, {"key": "9_CR183", "doi-asserted-by": "crossref", "first-page": "2731", "DOI": "10.1161/01.CIR.90.6.2731", "volume": "90", "author": "L Fananapazir", "year": "1994", "unstructured": "Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994;90:2731\u201342.", "journal-title": "Circulation"}, {"key": "9_CR184", "doi-asserted-by": "crossref", "first-page": "2927", "DOI": "10.1161/01.CIR.99.22.2927", "volume": "99", "author": "BJ Maron", "year": "1999", "unstructured": "Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999;99:2927\u201333.", "journal-title": "Circulation"}, {"key": "9_CR185", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1016/S0735-1097(96)00473-1", "volume": "29", "author": "RA Nishimura", "year": "1997", "unstructured": "Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997;29:435\u201341.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR186", "doi-asserted-by": "crossref", "first-page": "2281", "DOI": "10.1093/eurheartj/eht150", "volume": "34", "author": "M Brignole", "year": "2013", "unstructured": "Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padletti L, Sutton R, Vardas PE. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281\u2013329.", "journal-title": "Eur Heart J"}, {"key": "9_CR187", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1016/j.ejheart.2008.03.006", "volume": "10", "author": "DP Rogers", "year": "2008", "unstructured": "Rogers DP, Marazia S, Chow AW, Lambiase PD, Lowe MD, Frenneaux M, McKenna WJ, Elliott PM. Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy. Eur J Heart Fail. 2008;10:507\u201313.", "journal-title": "Eur J Heart Fail"}, {"key": "9_CR188", "first-page": "1308", "volume": "287", "author": "BJ Maron", "year": "2002", "unstructured": "Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308\u201320.", "journal-title": "JAMA"}, {"key": "9_CR189", "doi-asserted-by": "crossref", "first-page": "1965", "DOI": "10.1016/S0195-668X(03)00479-2", "volume": "24", "author": "BJ Maron", "year": "2003", "unstructured": "Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, et al. American College of Cardiology/European Society of Cardiology Clinical Expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines. Eur Heart J. 2003;24:1965\u201391.", "journal-title": "Eur Heart J"}, {"key": "9_CR190", "doi-asserted-by": "crossref", "first-page": "1283", "DOI": "10.1016/0735-1097(89)90302-1", "volume": "13", "author": "F Cecchi", "year": "1989", "unstructured": "Cecchi F, Maron BJ, Epstein SE. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol. 1989;13:1283\u20138.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR191", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1016/S0735-1097(99)00056-X", "volume": "33", "author": "PM Elliott", "year": "1999", "unstructured": "Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:1596\u2013601.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR192", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1016/0002-9149(78)90870-6", "volume": "41", "author": "BJ Maron", "year": "1978", "unstructured": "Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE. \u201cMalignant\u201d hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978;41:1133\u201340.", "journal-title": "Am J Cardiol"}, {"key": "9_CR193", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1016/0002-9149(81)90535-X", "volume": "47", "author": "W McKenna", "year": "1981", "unstructured": "McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532\u20138.", "journal-title": "Am J Cardiol"}, {"key": "9_CR194", "doi-asserted-by": "crossref", "first-page": "2212", "DOI": "10.1016/S0735-1097(00)01003-2", "volume": "36", "author": "PM Elliott", "year": "2000", "unstructured": "Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212\u20138.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR195", "doi-asserted-by": "crossref", "first-page": "1995", "DOI": "10.1161/01.CIR.82.6.1995", "volume": "82", "author": "MP Frenneaux", "year": "1990", "unstructured": "Frenneaux MP, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 1990;82:1995\u20132002.", "journal-title": "Circulation"}, {"key": "9_CR196", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.1016/S0735-1097(03)00827-1", "volume": "42", "author": "L Monserrat", "year": "2003", "unstructured": "Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol. 2003;42:873\u20139.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR197", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1016/S0140-6736(00)04005-8", "volume": "357", "author": "PM Elliott", "year": "2001", "unstructured": "Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420\u20134.", "journal-title": "Lancet"}, {"key": "9_CR198", "doi-asserted-by": "crossref", "first-page": "1778", "DOI": "10.1056/NEJM200006153422403", "volume": "342", "author": "P Spirito", "year": "2000", "unstructured": "Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778\u201385.", "journal-title": "N Engl J Med"}, {"issue": "30", "key": "9_CR199", "doi-asserted-by": "crossref", "first-page": "2010", "DOI": "10.1093/eurheartj/eht439", "volume": "35", "author": "C O'Mahony", "year": "2013", "unstructured": "O'Mahony C, Jichi F, Pavlou M, Monserrat L, Asatasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. 2013;35(30):2010\u201320.", "journal-title": "Eur Heart J"}, {"key": "9_CR200", "doi-asserted-by": "crossref", "first-page": "1933", "DOI": "10.1093/eurheartj/ehl041", "volume": "27", "author": "PM Elliott", "year": "2006", "unstructured": "Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1933\u201341.", "journal-title": "Eur Heart J"}, {"key": "9_CR201", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1056/NEJM200002103420601", "volume": "342", "author": "BJ Maron", "year": "2000", "unstructured": "Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365\u201373.", "journal-title": "N Engl J Med"}, {"key": "9_CR202", "first-page": "405", "volume": "298", "author": "BJ Maron", "year": "2007", "unstructured": "Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405\u201312.", "journal-title": "JAMA"}, {"key": "9_CR203", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1136/hrt.2006.094730", "volume": "93", "author": "JP Kaski", "year": "2007", "unstructured": "Kaski JP, Tome Esteban MT, Lowe M, Sporton S, Rees P, Deanfield JE, McKenna WJ, Elliott PM. Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy. Heart (British Cardiac Society). 2007;93:372\u20134.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR204", "doi-asserted-by": "crossref", "first-page": "800", "DOI": "10.1161/01.CIR.87.3.800", "volume": "87", "author": "MJ Silka", "year": "1993", "unstructured": "Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation. 1993;87:800\u20137.", "journal-title": "Circulation"}, {"issue": "10", "key": "9_CR205", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/j.jacc.2016.05.090", "volume": "68", "author": "V Favalli", "year": "2016", "unstructured": "Favalli V, Disabella E, Molinaro M, Tagliani M, Scarabotto A, Serio A, Grasso M, Narula N, Giorgianni C, Caspani C, Concardi M, Agozzino M, Giordano C, Smirmova A, Kodama T, Giuliani L, Antoniazzi E, Borroni RG, Vassallo C, Mangione F, Scelsi L, Ghio S, Pellegrini C, Zedde M, Fancellu L, Sechi G, Ganau A, Piga S, Colucci A, Concolino D, Di Mascio MT, Toni D, Diomedi M, Rapezzi C, Biagini E, Marini M, Rasura M, Melis M, Nucera A, Guidetti D, Mancuso M, Scoditti U, Cassini P, Narula J, Tavazzi L, Arbustini E. Genetic screening of Anderson-Fabry disease in probands referred from multispeciality clinics. J Am Coll Cardiol. 2016;68(10):1037\u201350.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR206", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1136/hrt.2005.063818", "volume": "93", "author": "A Linhart", "year": "2007", "unstructured": "Linhart A, Elliott PM. The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart (British Cardiac Society). 2007;93:528\u201335.", "journal-title": "Heart (British Cardiac Society)"}, {"issue": "12", "key": "9_CR207", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1136/heartjnl-2014-306782", "volume": "101", "author": "V Patel", "year": "2015", "unstructured": "Patel V, O'Mahony C, Hughes D, Rahman MS, Coats C, Murphy E, Lachmann R, Mehta A, Elliott PM. Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease. Heart. 2015;101(12):961\u20136.", "journal-title": "Heart"}, {"key": "9_CR208", "doi-asserted-by": "crossref", "first-page": "1101", "DOI": "10.1067/mhj.2000.105105", "volume": "139", "author": "A Linhart", "year": "2000", "unstructured": "Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudova J, Karetova D, Zeman J, Ledvinova J, Poupetova H, Elleder M, et al. New insights in cardiac structural changes in patients with Fabry\u2019s disease. Am Heart J. 2000;139:1101\u20138.", "journal-title": "Am Heart J"}, {"key": "9_CR209", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1111/j.1365-2362.2004.01309.x", "volume": "34", "author": "A Mehta", "year": "2004", "unstructured": "Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34:236\u201342.", "journal-title": "Eur J Clin Invest"}, {"key": "9_CR210", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1016/j.amjcard.2005.05.033", "volume": "96", "author": "JS Shah", "year": "2005", "unstructured": "Shah JS, Hughes DA, Sachdev B, Tome M, Ward D, Lee P, Mehta AB, Elliott PM. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005;96:842\u20136.", "journal-title": "Am J Cardiol"}, {"key": "9_CR211", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1161/CIRCULATIONAHA.108.794529", "volume": "119", "author": "F Weidemann", "year": "2009", "unstructured": "Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S, Voelker W, Ertl G, Wanner C, Stratmann J. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy. Circulation. 2009;119:524\u20139.", "journal-title": "Circulation"}, {"key": "9_CR212", "doi-asserted-by": "crossref", "first-page": "906", "DOI": "10.1038/35022604", "volume": "406", "author": "I Nishino", "year": "2000", "unstructured": "Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;406:906\u201310.", "journal-title": "Nature"}, {"key": "9_CR213", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1212/WNL.31.1.51", "volume": "31", "author": "MJ Danon", "year": "1981", "unstructured": "Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH. Lysosomal glycogen storage disease with normal acid maltase. Neurology. 1981;31:51\u20137.", "journal-title": "Neurology"}, {"key": "9_CR214", "doi-asserted-by": "crossref", "first-page": "1773", "DOI": "10.1212/WNL.58.12.1773", "volume": "58", "author": "K Sugie", "year": "2002", "unstructured": "Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology. 2002;58:1773\u20138.", "journal-title": "Neurology"}, {"issue": "6", "key": "9_CR215", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.1016/j.amjcard.2016.06.037", "volume": "118", "author": "L Fu", "year": "2016", "unstructured": "Fu L, Luo S, Cai S, Hong W, Guo Y, Wu J, Liu T, Zhao C, Li F, Huang H, Huang M, Wang J. Identification of LAMP2 mutations in early-onset Danon disease with hypertrophic cardiomyopathy by targeted next-generation sequencing. Am J Cardiol. 2016;118(6):888\u201394.", "journal-title": "Am J Cardiol"}, {"key": "9_CR216", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1097/GIM.0b013e31820ad795", "volume": "13", "author": "D Boucek", "year": "2011", "unstructured": "Boucek D, Jirikowic J, Taylor M. Natural history of Danon disease. Genet Med. 2011;13:563\u20138.", "journal-title": "Genet Med"}, {"key": "9_CR217", "doi-asserted-by": "crossref", "first-page": "1010", "DOI": "10.1016/j.ophtha.2006.02.030", "volume": "113", "author": "FR Prall", "year": "2006", "unstructured": "Prall FR, Drack A, Taylor M, Ku L, Olson JL, Gregory D, Mestroni L, Mandava N. Ophthalmic manifestations of Danon disease. Ophthalmology. 2006;113:1010\u20133.", "journal-title": "Ophthalmology"}, {"issue": "Suppl 3", "key": "9_CR218", "doi-asserted-by": "crossref", "first-page": "S389", "DOI": "10.1007/s10545-010-9195-2", "volume": "33", "author": "M Rizzo Del", "year": "2010", "unstructured": "Del Rizzo M, Fanin M, Cerutti A, Cazzorla C, Milanesi O, Nascimbeni AC, Angelini C, Giordano L, Bordugo A, Burlina AB. Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report. J Inherit Metab Dis. 2010;33(Suppl 3):S389\u201393.", "journal-title": "J Inherit Metab Dis"}, {"key": "9_CR219", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/j.nmd.2004.10.009", "volume": "15", "author": "L Klinge", "year": "2005", "unstructured": "Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Gorlinger K, Wallot M, Richards S, Voit T. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord. 2005;15:24\u201331.", "journal-title": "Neuromuscul Disord"}, {"issue": "3", "key": "9_CR220", "first-page": "202", "volume": "30", "author": "G Limongelli", "year": "2011", "unstructured": "Limongelli G, Fratta F. S1.4 cardiovascular involvement in Pompe disease. Acta Myol. 2011;30(3):202\u20133.", "journal-title": "Acta Myol"}, {"key": "9_CR221", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1093/hmg/10.11.1215", "volume": "10", "author": "E Blair", "year": "2001", "unstructured": "Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma (2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet. 2001;10:1215\u201320.", "journal-title": "Hum Mol Genet"}, {"issue": "9", "key": "9_CR222", "doi-asserted-by": "crossref", "first-page": "e17", "DOI": "10.1016/j.jacc.2013.02.099", "volume": "62", "author": "E Fabris", "year": "2013", "unstructured": "Fabris E, Brun F, Porto AG, Losurdo P, Serdoz LV, Zecchin M, Severini GM, Mestroni L, Di Chiara A, Sinagra G. Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent\u2014the PRKAG2 cardiac syndrome. JACC. 2013;62(9):e17.", "journal-title": "JACC"}, {"issue": "4", "key": "9_CR223", "first-page": "651", "volume": "19", "author": "J Thevenon", "year": "2017", "unstructured": "Thevenon J, Laurent G, Ader F, Laforet P, Klug D, Duva Pentiah A, Gouya L, Maurage CA, Kacet S, Eicher JC, Albuisson J, Desnos M, Bieth E, Duboc D, Martin L, Reant P, Picard F, Bonithon-Kopp C, Gautier E, Binquet C, Thauvin-Robinet C, Faivre L, Bouvagnet P, Charron P, Richard P. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations. Europace. 2017;19(4):651\u20139.", "journal-title": "Europace"}, {"key": "9_CR224", "doi-asserted-by": "crossref", "first-page": "1034", "DOI": "10.1086/430840", "volume": "76", "author": "B Burwinkel", "year": "2005", "unstructured": "Burwinkel B, Scott JW, Buhrer C, van Landeghem FKH, Cox GF, Wilson CJ, Hardie DG, Kilimann MW. Fatal congenital heart glycogenesis caused by a recurrent activating R531Q mutation in the gamma2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet. 2005;76:1034\u201349.", "journal-title": "Am J Hum Genet"}, {"issue": "4", "key": "9_CR225", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1016/j.jelectrocard.2010.02.009", "volume": "44", "author": "L-P Zhang", "year": "2011", "unstructured": "Zhang L-P, Hui B, Gao B-R. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome. J Electrocardiol. 2011;44(4):483\u20136.", "journal-title": "J Electrocardiol"}, {"key": "9_CR226", "doi-asserted-by": "crossref", "first-page": "922", "DOI": "10.1016/j.jacc.2004.11.053", "volume": "45", "author": "RT Murphy", "year": "2005", "unstructured": "Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E, Syrris P, Gorman G, Farrell M, Holton JL, et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol. 2005;45:922\u201330.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR227", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1161/CIRCULATIONAHA.107.747345", "volume": "117", "author": "MH Gollob", "year": "2008", "unstructured": "Gollob MH. Modulating phenotypic expression of the PRKAG2 Cardiac syndrome. Circulation. 2008;117:134\u20135.", "journal-title": "Circulation"}, {"key": "9_CR228", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1542/peds.2004-0718", "volume": "114", "author": "F Scaglia", "year": "2004", "unstructured": "Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, Neish SR, Ware SM, Hunter JV, Fernbach SD, Vladutiu GD, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114:925\u201331.", "journal-title": "Pediatrics"}, {"key": "9_CR229", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1016/S0195-668X(02)00387-1", "volume": "24", "author": "D Holmgren", "year": "2003", "unstructured": "Holmgren D, Wahlander H, Eriksson BO, Oldfors A, Holme E, Tulinius M. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J. 2003;24:280\u20138.", "journal-title": "Eur Heart J"}, {"key": "9_CR230", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1136/heartjnl-2015-308193", "volume": "103", "author": "G Limongelli", "year": "2017", "unstructured": "Limongelli G, Masarone D, Pacileo G. Mitochondrial disease and the heart. Heart. 2017;103:390\u20138.", "journal-title": "Heart"}, {"key": "9_CR231", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1186/1471-2261-2-12", "volume": "2", "author": "K Majamaa-Voltti", "year": "2002", "unstructured": "Majamaa-Voltti K, Peuhkurinen K, Kortelainen MJ, Hassinen IE, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord. 2002;2:12. https://doi.org/10.1186/1471-2261-2-12 .", "journal-title": "BMC Cardiovasc Disord"}, {"issue": "4", "key": "9_CR232", "first-page": "385", "volume": "40", "author": "DE Meyers", "year": "2013", "unstructured": "Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy\u2014pathophysiology, diagnosis and management. Tex Heart Inst J. 2013;40(4):385\u201394.", "journal-title": "Tex Heart Inst J"}, {"issue": "8", "key": "9_CR233", "doi-asserted-by": "crossref", "first-page": "674", "DOI": "10.1212/WNL.0b013e3181d0ccf4", "volume": "74", "author": "K Wahbi", "year": "2010", "unstructured": "Wahbi K, Larue S, Jardel C, Meune C, Stojkovic T, Ziegler F, et al. Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology. 2010;74(8):674\u20137.", "journal-title": "Neurology"}, {"key": "9_CR234", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1016/S0735-1097(86)80159-0", "volume": "7", "author": "JS Child", "year": "1986", "unstructured": "Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA. Cardiac involvement in Friedreich\u2019s ataxia: a clinical study of 75 patients. J Am Coll Cardiol. 1986;7:1370\u20138.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR235", "first-page": "423", "volume": "35", "author": "F Casazza", "year": "1990", "unstructured": "Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M. Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia (Rome, Italy). 1990;35:423\u201331.", "journal-title": "Cardiologia (Rome, Italy)"}, {"key": "9_CR236", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1161/CIRCULATIONAHA.112.095364", "volume": "125", "author": "MK Jensen", "year": "2012", "unstructured": "Jensen MK, Bundgaard H. Cardiomyopathy in Friedreich Ataxia\u2014exemplifying the challenges faced by cardiologists in the management of rare diseases. Circulation. 2012;125:1591\u20133.", "journal-title": "Circulation"}, {"key": "9_CR237", "first-page": "468", "volume": "63", "author": "JA Noonan", "year": "1963", "unstructured": "Noonan JA, Ehmke DA. Associated noncardiac malformations in children with congenital heart disease. J Pediatr. 1963;63:468.", "journal-title": "J Pediatr"}, {"key": "9_CR238", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1001/archpedi.1968.02100020377005", "volume": "116", "author": "JA Noonan", "year": "1968", "unstructured": "Noonan JA. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child. 1968;116:373\u201380.", "journal-title": "Am J Dis Child"}, {"key": "9_CR239", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1146/annurev.genom.6.080604.162305", "volume": "6", "author": "M Tartaglia", "year": "2005", "unstructured": "Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005;6:45\u201368.", "journal-title": "Annu Rev Genomics Hum Genet"}, {"key": "9_CR240", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1136/adc.67.2.178", "volume": "67", "author": "M Sharland", "year": "1992", "unstructured": "Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67:178\u201383.", "journal-title": "Arch Dis Child"}, {"key": "9_CR241", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1136/hrt.68.12.586", "volume": "68", "author": "M Burch", "year": "1992", "unstructured": "Burch M, Mann JM, Sharland M, Shinebourne EA, Patton MA, McKenna WJ. Myocardial disarray in Noonan syndrome. Br Heart J. 1992;68:586\u20138.", "journal-title": "Br Heart J"}, {"key": "9_CR242", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1038/73528", "volume": "24", "author": "B Chen", "year": "2000", "unstructured": "Chen B, Bronson RT, Klaman LD, Hampton TG, Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP, Neel BG. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet. 2000;24:296\u20139.", "journal-title": "Nat Genet"}, {"key": "9_CR243", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1038/ng772", "volume": "29", "author": "M Tartaglia", "year": "2001", "unstructured": "Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465\u20138.", "journal-title": "Nat Genet"}, {"key": "9_CR244", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1038/ng1939", "volume": "39", "author": "M Tartaglia", "year": "2007", "unstructured": "Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2007;39:75\u20139.", "journal-title": "Nat Genet"}, {"key": "9_CR245", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1038/ng1926", "volume": "39", "author": "AE Roberts", "year": "2007", "unstructured": "Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet. 2007;39:70\u20134.", "journal-title": "Nat Genet"}, {"key": "9_CR246", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1136/jmg.2007.051276", "volume": "44", "author": "M Zenker", "year": "2007", "unstructured": "Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, van der Burgt I, Doerr HG, Gaspar H, Hofbeck M, Gillessen-Kaesbach G, et al. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet. 2007;44:651\u20136.", "journal-title": "J Med Genet"}, {"key": "9_CR247", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1038/ng1748", "volume": "38", "author": "S Schubbert", "year": "2006", "unstructured": "Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331\u20136.", "journal-title": "Nat Genet"}, {"key": "9_CR248", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1038/ng2073", "volume": "39", "author": "B Pandit", "year": "2007", "unstructured": "Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39:1007\u201312.", "journal-title": "Nat Genet"}, {"key": "9_CR249", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1038/ng2078", "volume": "39", "author": "MA Razzaque", "year": "2007", "unstructured": "Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007;39:1013\u20137.", "journal-title": "Nat Genet"}, {"key": "9_CR250", "doi-asserted-by": "crossref", "first-page": "1555", "DOI": "10.1086/340847", "volume": "70", "author": "M Tartaglia", "year": "2002", "unstructured": "Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70:1555\u201363.", "journal-title": "Am J Hum Genet"}, {"key": "9_CR251", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1016/j.jpeds.2003.11.032", "volume": "144", "author": "M Zenker", "year": "2004", "unstructured": "Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, Tietze HU, Doerr HG, Hofbeck M, Singer H, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004;144:368\u201374.", "journal-title": "J Pediatr"}, {"issue": "3", "key": "9_CR252", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1016/j.ahj.2012.04.018", "volume": "164", "author": "JD Wilkinson", "year": "2012", "unstructured": "Wilkinson JD, Lowe AM, Salbert BA, Sleeper LA, Colan SD, Cox GF, Towbin JA, Connuck DM, Messere JE, Lipshultz SE. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2012;164(3):442\u20138.", "journal-title": "Am Heart J"}, {"key": "9_CR253", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1086/341528", "volume": "71", "author": "MC Digilio", "year": "2002", "unstructured": "Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002;71:389\u201394.", "journal-title": "Am J Hum Genet"}, {"key": "9_CR254", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1016/j.amjcard.2007.03.093", "volume": "100", "author": "G Limongelli", "year": "2007", "unstructured": "Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P, Versacci P, Calabro P, De Zorzi A, Di Salvo G, Syrris P, Patton M, McKenna WJ, Dallapiccola B, Calabro R. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol. 2007;100:736\u201341.", "journal-title": "Am J Cardiol"}, {"key": "9_CR255", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1186/1750-1172-3-13", "volume": "3", "author": "A Sarkozy", "year": "2008", "unstructured": "Sarkozy A, Digilio MC, Dallapiccola B. Leopard syndrome. Orphanet J Rare Dis. 2008;3:13.", "journal-title": "Orphanet J Rare Dis"}, {"key": "9_CR256", "doi-asserted-by": "crossref", "first-page": "1415", "DOI": "10.1378/chest.113.5.1415", "volume": "113", "author": "A Woywodt", "year": "1998", "unstructured": "Woywodt A, Welzel J, Haase H, Duerholz A, Wiegand U, Potratz J, Sheikhzadeh A. Cardiomyopathic lentiginosis/LEOPARD syndrome presenting as sudden cardiac arrest. Chest. 1998;113:1415\u20137.", "journal-title": "Chest"}, {"key": "9_CR257", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1186/1750-1172-1-27", "volume": "1", "author": "MRG Taylor", "year": "2006", "unstructured": "Taylor MRG, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orphanet J Rare Dis. 2006;1:27.", "journal-title": "Orphanet J Rare Dis"}, {"key": "9_CR258", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/S0735-1097(97)00434-8", "volume": "31", "author": "E Grunig", "year": "1998", "unstructured": "Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 1998;31:186\u201394.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR259", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/S0735-1097(97)00433-6", "volume": "31", "author": "MK Baig", "year": "1998", "unstructured": "Baig MK, Goldman JH, Caforio AL, Coonar AS, Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol. 1998;31:195\u2013201.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR260", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.7326/0003-4819-143-2-200507190-00009", "volume": "143", "author": "NG Mahon", "year": "2005", "unstructured": "Mahon NG, Murphy RT, MacRae CA, Caforio AL, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med. 2005;143:108\u201315.", "journal-title": "Ann Intern Med"}, {"key": "9_CR261", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1007/s000590050003", "volume": "25", "author": "NE Bowles", "year": "2000", "unstructured": "Bowles NE, Bowles KR, Towbin JA. The \u201cfinal common pathway\u201d hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 2000;25:168\u201375.", "journal-title": "Herz"}, {"issue": "1", "key": "9_CR262", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1172/JCI62862", "volume": "123", "author": "EM McNally", "year": "2013", "unstructured": "McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123(1):19\u201326.", "journal-title": "J Clin Invest"}, {"key": "9_CR263", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1172/JCI9224", "volume": "106", "author": "S Tsubata", "year": "2000", "unstructured": "Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest. 2000;106:655\u201362.", "journal-title": "J Clin Invest"}, {"key": "9_CR264", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1136/jmg.37.2.102", "volume": "37", "author": "R Barresi", "year": "2000", "unstructured": "Barresi R, Di Blasi C, Negri T, Brugnoni R, Vitali A, Felisari G, Salandi A, Daniel S, Cornelio F, Morandi L, et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet. 2000;37:102\u20137.", "journal-title": "J Med Genet"}, {"issue": "7", "key": "9_CR265", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1056/NEJMoa1110186", "volume": "366", "author": "DS Herman", "year": "2012", "unstructured": "Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366(7):619\u201328.", "journal-title": "N Engl J Med"}, {"key": "9_CR266", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1126/science.280.5364.750", "volume": "280", "author": "TM Olson", "year": "1998", "unstructured": "Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (New York, NY). 1998;280:750\u20132.", "journal-title": "Science (New York, NY)"}, {"key": "9_CR267", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1056/NEJM200012073432304", "volume": "343", "author": "M Kamisago", "year": "2000", "unstructured": "Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343:1688\u201396.", "journal-title": "N Engl J Med"}, {"key": "9_CR268", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1017/S1047951107001291", "volume": "17", "author": "JP Kaski", "year": "2007", "unstructured": "Kaski JP, Burch M, Elliott PM. Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood. Cardiol Young. 2007;17:675\u20137.", "journal-title": "Cardiol Young"}, {"key": "9_CR269", "doi-asserted-by": "crossref", "first-page": "2033", "DOI": "10.1016/j.jacc.2004.08.027", "volume": "44", "author": "J Mogensen", "year": "2004", "unstructured": "Mogensen J, Murphy RT, Shaw T, Bahl A, Redwood C, Watkins H, Burke M, Elliott PM, McKenna WJ. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2004;44:2033\u201340.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR270", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1006/jmcc.2000.1339", "volume": "33", "author": "TM Olson", "year": "2001", "unstructured": "Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol. 2001;33:723\u201332.", "journal-title": "J Mol Cell Cardiol"}, {"issue": "2", "key": "9_CR271", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1161/CIRCRESAHA.106.146670", "volume": "101", "author": "CK Du", "year": "2007", "unstructured": "Du CK, et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res. 2007;101(2):185\u201394.", "journal-title": "Circ Res"}, {"issue": "23", "key": "9_CR272", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1056/NEJM200012073432304", "volume": "343", "author": "M Karmisago", "year": "2000", "unstructured": "Karmisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343(23):1688\u201396.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "9_CR273", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1016/j.jacc.2009.11.017", "volume": "55", "author": "NK Lakdawala", "year": "2010", "unstructured": "Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, Depalma S, Colan SD, Funke B, Zimmerman RS, Robinson P, Watkins H, Seidman CE, Seidman JG, McNally EM, Ho CY. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol. 2010;55(4):320\u20139.", "journal-title": "J Am Coll Cardiol"}, {"issue": "22", "key": "9_CR274", "doi-asserted-by": "crossref", "first-page": "2893", "DOI": "10.1161/CIRCULATIONAHA.107.746164", "volume": "117", "author": "S Klaassen", "year": "2008", "unstructured": "Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hurlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L. Mutations in sarcomere protein genes in left ventricular nocompaction. Circulation. 2008;117(22):2893\u2013901.", "journal-title": "Circulation"}, {"issue": "8", "key": "9_CR275", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1161/01.RES.0000126574.61061.25", "volume": "94", "author": "KA Lapidos", "year": "2004", "unstructured": "Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res. 2004;94(8):1023\u201331.", "journal-title": "Circ Res"}, {"issue": "7053", "key": "9_CR276", "doi-asserted-by": "crossref", "first-page": "1025", "DOI": "10.1038/nature03844", "volume": "436", "author": "S Yasuda", "year": "2005", "unstructured": "Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature. 2005;436(7053):1025\u20139.", "journal-title": "Nature"}, {"key": "9_CR277", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1038/415227a", "volume": "415", "author": "JA Towbin", "year": "2002", "unstructured": "Towbin JA, Bowles NE. The failing heart. Nature. 2002;415:227\u201333.", "journal-title": "Nature"}, {"key": "9_CR278", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1161/01.CIR.101.5.473", "volume": "101", "author": "GL Brodsky", "year": "2000", "unstructured": "Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000;101:473\u20136.", "journal-title": "Circulation"}, {"key": "9_CR279", "doi-asserted-by": "crossref", "first-page": "1715", "DOI": "10.1056/NEJM199912023412302", "volume": "341", "author": "D Fatkin", "year": "1999", "unstructured": "Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ Jr, Spudich S, De Girolami U, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715\u201324.", "journal-title": "N Engl J Med"}, {"key": "9_CR280", "doi-asserted-by": "crossref", "first-page": "546", "DOI": "10.1038/ng0894-546", "volume": "7", "author": "S Kass", "year": "1994", "unstructured": "Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB 3rd, Cody RJ, Fishman MC, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet. 1994;7:546\u201351.", "journal-title": "Nat Genet"}, {"key": "9_CR281", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1038/6799", "volume": "21", "author": "G Bonne", "year": "1999", "unstructured": "Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21:285\u20138.", "journal-title": "Nat Genet"}, {"key": "9_CR282", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1093/hmg/9.9.1453", "volume": "9", "author": "A Muchir", "year": "2000", "unstructured": "Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA, de Visser M, Schwartz K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet. 2000;9:1453\u20139.", "journal-title": "Hum Mol Genet"}, {"key": "9_CR283", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1038/72807", "volume": "24", "author": "S Shackleton", "year": "2000", "unstructured": "Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153\u20136.", "journal-title": "Nat Genet"}, {"issue": "6", "key": "9_CR284", "doi-asserted-by": "crossref", "first-page": "981", "DOI": "10.1016/S0735-1097(02)01724-2", "volume": "39", "author": "E Arbustini", "year": "2002", "unstructured": "Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol. 2002;39(6):981\u201390.", "journal-title": "J Am Coll Cardiol"}, {"issue": "5", "key": "9_CR285", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/j.jacc.2011.08.078", "volume": "59", "author": "IA Rijsingen Van", "year": "2012", "unstructured": "Van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Pilotto A, Pasotti M, Jenkins S, Rowland C, Aslam U, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH, Charron P, Pinto YM. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493\u2013500.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR286", "doi-asserted-by": "crossref", "first-page": "940", "DOI": "10.1038/nrg1906", "volume": "7", "author": "BC Capell", "year": "2006", "unstructured": "Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. Nat Rev. 2006;7:940\u201352.", "journal-title": "Nat Rev"}, {"key": "9_CR287", "doi-asserted-by": "crossref", "first-page": "2121", "DOI": "10.1016/j.yexcr.2007.03.028", "volume": "313", "author": "HJ Worman", "year": "2007", "unstructured": "Worman HJ, Bonne G. \u201cLaminopathies\u201d: a wide spectrum of human diseases. Exp Cell Res. 2007;313:2121\u201333.", "journal-title": "Exp Cell Res"}, {"key": "9_CR288", "doi-asserted-by": "crossref", "first-page": "2567", "DOI": "10.1093/hmg/ddh295", "volume": "13", "author": "JL Broers", "year": "2004", "unstructured": "Broers JL, Peeters EA, Kuijpers HJ, Endert J, Bouten CV, Oomens CW, Baaijens FP, Ramaekers FC. Decreased mechanical stiffness in LMNA\u2212/\u2212 cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet. 2004;13:2567\u201380.", "journal-title": "Hum Mol Genet"}, {"key": "9_CR289", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1172/JCI200419670", "volume": "113", "author": "J Lammerding", "year": "2004", "unstructured": "Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest. 2004;113:370\u20138.", "journal-title": "J Clin Invest"}, {"key": "9_CR290", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1083/jcb.147.5.913", "volume": "147", "author": "T Sullivan", "year": "1999", "unstructured": "Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol. 1999;147:913\u201320.", "journal-title": "J Cell Biol"}, {"issue": "22", "key": "9_CR291", "doi-asserted-by": "crossref", "first-page": "2440", "DOI": "10.1016/j.jacc.2016.09.927", "volume": "68", "author": "MF Ortiz-Genga", "year": "2016", "unstructured": "Ortiz-Genga MF, Cuenca S, Del Ferro M, Zorio E, Salgado-Arnanda R, Climent V, Padron-Barthe L, Duro-Aguado I, Jimenez-Jaimez J, Hidalgo-Olivares VM, Garcia-Campo E, Lanzillo C, Suarez-Mier P, Yonath H, Marcos-Alonso S, Ochoa JP, Santome JL, Garcia-Giustiniani D, Rodriguez-Garrido JL, Dominguez F, Merlo M, Palomino J, Pena ML, Trujillo JP, Martin-Vila A, Stolfo D, Molina P, Lara-Pezzi E, Calvo-Iglesias FE, Nof E, Calo L, Barriales-Villa R, Gimeno-Blanes JR, Arad M, Garcia-Pavo P, Monserrat L. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68(22):2440\u201351.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR292", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1136/hrt.2003.023390", "volume": "90", "author": "N Cohen", "year": "2004", "unstructured": "Cohen N, Muntoni F. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart (British Cardiac Society). 2004;90:835\u201341.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR293", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1056/NEJM199309233291304", "volume": "329", "author": "F Muntoni", "year": "1993", "unstructured": "Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921\u20135.", "journal-title": "N Engl J Med"}, {"key": "9_CR294", "doi-asserted-by": "crossref", "first-page": "1854", "DOI": "10.1161/01.CIR.87.6.1854", "volume": "87", "author": "JA Towbin", "year": "1993", "unstructured": "Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854\u201365.", "journal-title": "Circulation"}, {"key": "9_CR295", "doi-asserted-by": "crossref", "first-page": "1867", "DOI": "10.1001/jama.296.15.1867", "volume": "296", "author": "JA Towbin", "year": "2006", "unstructured": "Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867\u201376.", "journal-title": "JAMA"}, {"key": "9_CR296", "doi-asserted-by": "crossref", "first-page": "1186", "DOI": "10.1056/NEJM198705073161904", "volume": "316", "author": "BA Berko", "year": "1987", "unstructured": "Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med. 1987;316:1186\u201391.", "journal-title": "N Engl J Med"}, {"key": "9_CR297", "doi-asserted-by": "crossref", "first-page": "1335", "DOI": "10.1001/jama.1996.03530410049032", "volume": "275", "author": "L Politano", "year": "1996", "unstructured": "Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, Di Somma S, Comi LI. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996;275:1335\u20138.", "journal-title": "JAMA"}, {"key": "9_CR298", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/0022-510X(83)90209-5", "volume": "62", "author": "PG Barth", "year": "1983", "unstructured": "Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen IE, Van't Veer-Korthof ET, Van der Harten JJ, Sobotka-Plojhar MA. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci. 1983;62:327\u201355.", "journal-title": "J Neurol Sci"}, {"key": "9_CR299", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.1016/S0022-3476(05)80289-6", "volume": "119", "author": "RI Kelley", "year": "1991", "unstructured": "Kelley RI, Cheatham JP, Clark BJ, Nigro MA, Powell BR, Sherwood GW, Sladky JT, Swisher WP. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr. 1991;119:738\u201347.", "journal-title": "J Pediatr"}, {"key": "9_CR300", "doi-asserted-by": "crossref", "first-page": "868", "DOI": "10.1086/514879", "volume": "61", "author": "SB Bleyl", "year": "1997", "unstructured": "Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, Ward K. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet. 1997;61:868\u201372.", "journal-title": "Am J Hum Genet"}, {"key": "9_CR301", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1086/514886", "volume": "61", "author": "P D'Adamo", "year": "1997", "unstructured": "D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, Barth PG, Wilson M, Haan E, Orstavik KH, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet. 1997;61:862\u20137.", "journal-title": "Am J Hum Genet"}, {"issue": "9", "key": "9_CR302", "doi-asserted-by": "crossref", "first-page": "1114", "DOI": "10.1016/S0002-9149(00)00706-2", "volume": "85", "author": "A Gavazzi", "year": "2000", "unstructured": "Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and dilated cardiomyopathy in men. Am J Cardiol. 2000;85(9):1114\u20138.", "journal-title": "Am J Cardiol"}, {"key": "9_CR303", "doi-asserted-by": "crossref", "first-page": "1388", "DOI": "10.1056/NEJM200011093431908", "volume": "343", "author": "AM Feldman", "year": "2000", "unstructured": "Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388\u201398.", "journal-title": "N Engl J Med"}, {"key": "9_CR304", "doi-asserted-by": "crossref", "first-page": "2636", "DOI": "10.1093/eurheartj/eht210", "volume": "34", "author": "ALP Caforio", "year": "2013", "unstructured": "Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636\u201348.", "journal-title": "Eur Heart J"}, {"key": "9_CR305", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1161/CIRCULATIONAHA.105.584532", "volume": "113", "author": "JW Magnani", "year": "2006", "unstructured": "Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876\u201390.", "journal-title": "Circulation"}, {"key": "9_CR306", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1007/s00059-005-2730-5", "volume": "30", "author": "B Maisch", "year": "2005", "unstructured": "Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S. Inflammatory dilated cardiomyopathy (DCMI). Herz. 2005;30:535\u201344.", "journal-title": "Herz"}, {"key": "9_CR307", "doi-asserted-by": "crossref", "first-page": "2124", "DOI": "10.1161/01.CIR.99.16.2124", "volume": "99", "author": "M Noutsias", "year": "1999", "unstructured": "Noutsias M, Seeberg B, Schultheiss HP, Kuhl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation. 1999;99:2124\u201331.", "journal-title": "Circulation"}, {"key": "9_CR308", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1016/S0140-6736(94)92339-6", "volume": "344", "author": "AL Caforio", "year": "1994", "unstructured": "Caforio AL, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 1994;344:773\u20137.", "journal-title": "Lancet"}, {"key": "9_CR309", "first-page": "62", "volume": "77", "author": "AL Caforio", "year": "1997", "unstructured": "Caforio AL, Goldman JH, Baig MK, Haven AJ, Dalla LL, Keeling PJ, McKenna WJ. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart (British Cardiac Society). 1997;77:62\u20137.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR310", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/S1388-9842(02)00010-7", "volume": "4", "author": "AL Caforio", "year": "2002", "unstructured": "Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail. 2002;4:411\u20137.", "journal-title": "Eur J Heart Fail"}, {"issue": "15", "key": "9_CR311", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1161/CIRCULATIONAHA.105.606509", "volume": "114", "author": "H Mahrholdt", "year": "2006", "unstructured": "Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager C, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581\u201390.", "journal-title": "Circulation"}, {"key": "9_CR312", "doi-asserted-by": "crossref", "first-page": "3549", "DOI": "10.1161/01.CIR.96.10.3549", "volume": "96", "author": "KO Schowengerdt", "year": "1997", "unstructured": "Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, Kearney DL, Price JK, Rogers BB, Schauer GM, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation. 1997;96:3549\u201354.", "journal-title": "Circulation"}, {"key": "9_CR313", "first-page": "539", "volume": "78", "author": "C Baboonian", "year": "1997", "unstructured": "Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart (British Cardiac Society). 1997;78:539\u201343.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR314", "doi-asserted-by": "crossref", "first-page": "887", "DOI": "10.1161/01.CIR.0000155616.07901.35", "volume": "111", "author": "U Kuhl", "year": "2005", "unstructured": "Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation. 2005;111:887\u201393.", "journal-title": "Circulation"}, {"key": "9_CR315", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1172/JCI1972", "volume": "102", "author": "R Wessely", "year": "1998", "unstructured": "Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest. 1998;102:1444\u201353.", "journal-title": "J Clin Invest"}, {"key": "9_CR316", "first-page": "699", "volume": "15", "author": "M Abdullah", "year": "1999", "unstructured": "Abdullah M, Bigras JL, McCrindle BW. Dilated cardiomyopathy as a first sign of nutritional vitamin D deficiency rickets in infancy. Can J Cardiol. 1999;15:699\u2013701.", "journal-title": "Can J Cardiol"}, {"key": "9_CR317", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1007/BF02723209", "volume": "68", "author": "S Gulati", "year": "2001", "unstructured": "Gulati S, Bajpai A, Juneja R, Kabra M, Bagga A, Kalra V. Hypocalcemic heart failure masquerading as dilated cardiomyopathy. Indian J Pediatr. 2001;68:287\u201390.", "journal-title": "Indian J Pediatr"}, {"key": "9_CR318", "first-page": "413", "volume": "43", "author": "P Labrune", "year": "1986", "unstructured": "Labrune P, Bader B, Devictor D, Madelin JC, Huault G. Hypocalcemia, cardiac failure and ventricular tachycardia in an infant with rickets. Arch Fr Pediatr. 1986;43:413\u20135.", "journal-title": "Arch Fr Pediatr"}, {"key": "9_CR319", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1136/hrt.2007.119792", "volume": "94", "author": "S Maiya", "year": "2008", "unstructured": "Maiya S, Sullivan I, Allgrove J, Yates R, Malone M, Brain C, Archer N, Mok Q, Daubeney P, Tulloh R, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart (British Cardiac Society). 2008;94:581\u20134.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR320", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1007/s00246-002-0251-z", "volume": "24", "author": "DI Price", "year": "2003", "unstructured": "Price DI, Stanford LC Jr, Braden DS, Ebeid MR, Smith JC. Hypocalcemic rickets: an unusual cause of dilated cardiomyopathy. Pediatr Cardiol. 2003;24:510\u20132.", "journal-title": "Pediatr Cardiol"}, {"key": "9_CR321", "first-page": "547", "volume": "48", "author": "H Yaseen", "year": "1993", "unstructured": "Yaseen H, Maragnes P, Gandon-Laloum S, Bensaid P, N'Guyen B, Ricaud D, Lecacheux C. A severe form of vitamin D deficiency with hypocalcemic cardiomyopathy. Pediatrie. 1993;48:547\u20139.", "journal-title": "Pediatrie"}, {"key": "9_CR322", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1136/hrt.2004.040337", "volume": "91", "author": "SE Hughes", "year": "2005", "unstructured": "Hughes SE, McKenna WJ. New insights into the pathology of inherited cardiomyopathy. Heart (British Cardiac Society). 2005;91:257\u201364.", "journal-title": "Heart (British Cardiac Society)"}, {"issue": "27", "key": "9_CR323", "doi-asserted-by": "crossref", "first-page": "2129", "DOI": "10.1093/eurheartj/ehw128", "volume": "37", "author": "P Ponikowski", "year": "2016", "unstructured": "Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.", "journal-title": "Eur Heart J"}, {"key": "9_CR324", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1016/0735-1097(89)90293-3", "volume": "13", "author": "WH Abelmann", "year": "1989", "unstructured": "Abelmann WH, Lorell BH. The challenge of cardiomyopathy. J Am Coll Cardiol. 1989;13:1219\u201339.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR325", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1136/hrt.72.3.246", "volume": "72", "author": "M Burch", "year": "1994", "unstructured": "Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J. 1994;72:246\u201350.", "journal-title": "Br Heart J"}, {"key": "9_CR326", "doi-asserted-by": "crossref", "first-page": "2671", "DOI": "10.1161/CIRCULATIONAHA.106.635128", "volume": "114", "author": "PE Daubeney", "year": "2006", "unstructured": "Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671\u20138.", "journal-title": "Circulation"}, {"key": "9_CR327", "first-page": "721", "volume": "6", "author": "M Zecchin", "year": "2005", "unstructured": "Zecchin M, Di Lenarda A, Gregori D, Moretti M, Driussi M, Aleksova A, Chersevani D, Sabbadini G, Sinagra G. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy. Ital Heart J. 2005;6:721\u20137.", "journal-title": "Ital Heart J"}, {"key": "9_CR328", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1016/S0735-1097(10)80233-5", "volume": "18", "author": "RA Friedman", "year": "1991", "unstructured": "Friedman RA, Moak JP, Garson A Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol. 1991;18:152\u20136.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR329", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1136/heart.84.1.106", "volume": "84", "author": "P Elliott", "year": "2000", "unstructured": "Elliott P. Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy. Heart (British Cardiac Society). 2000;84:106\u201312.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR330", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1161/01.CIR.62.5.1054", "volume": "62", "author": "WL Henry", "year": "1980", "unstructured": "Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980;62:1054\u201361.", "journal-title": "Circulation"}, {"key": "9_CR331", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1161/01.CIR.93.5.841", "volume": "93", "author": "P Richardson", "year": "1996", "unstructured": "Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841\u20132.", "journal-title": "Circulation"}, {"key": "9_CR332", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1136/hrt.2005.080481", "volume": "92", "author": "AR Doughan", "year": "2006", "unstructured": "Doughan AR, Williams BR. Cardiac sarcoidosis. Heart (British Cardiac Society). 2006;92:282\u20138.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR333", "doi-asserted-by": "crossref", "first-page": "1063", "DOI": "10.1161/CIRCULATIONAHA.105.608869", "volume": "114", "author": "JF Price", "year": "2006", "unstructured": "Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, Towbin JA, Dreyer WJ. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114:1063\u20139.", "journal-title": "Circulation"}, {"key": "9_CR334", "doi-asserted-by": "crossref", "first-page": "816", "DOI": "10.1378/chest.120.3.816", "volume": "120", "author": "GV Guimaraes", "year": "2001", "unstructured": "Guimaraes GV, Bellotti G, Mocelin AO, Camargo PR, Bocchi EA. Cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy. Chest. 2001;120:816\u201324.", "journal-title": "Chest"}, {"key": "9_CR335", "doi-asserted-by": "crossref", "first-page": "3079", "DOI": "10.1161/01.CIR.0000041428.99427.06", "volume": "106", "author": "AK Gitt", "year": "2002", "unstructured": "Gitt AK, Wasserman K, Kilkwski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079\u201384.", "journal-title": "Circulation"}, {"key": "9_CR336", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1161/01.CIR.69.1.93", "volume": "69", "author": "JE Parrillo", "year": "1984", "unstructured": "Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation. 1984;69:93\u2013101.", "journal-title": "Circulation"}, {"key": "9_CR337", "doi-asserted-by": "crossref", "first-page": "3076", "DOI": "10.1093/eurheartj/ehm456", "volume": "28", "author": "LT Cooper", "year": "2007", "unstructured": "Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007;28:3076\u201393.", "journal-title": "Eur Heart J"}, {"key": "9_CR338", "doi-asserted-by": "crossref", "first-page": "1649", "DOI": "10.1016/j.jacc.2005.11.067", "volume": "47", "author": "F Cobelli De", "year": "2006", "unstructured": "De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47:1649\u201354.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR339", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1056/NEJM199909023411001", "volume": "341", "author": "B Pitt", "year": "1999", "unstructured": "Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709\u201317.", "journal-title": "N Engl J Med"}, {"key": "9_CR340", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1056/NEJMoa1009492", "volume": "364", "author": "F Zannad", "year": "2011", "unstructured": "Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedburg K, Shi H, Vincent J, Pocock SJ, Pitt B for the EMPHASIS-HF Study Group. Epleronone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11\u201321.", "journal-title": "N Engl J Med"}, {"key": "9_CR341", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1016/j.healun.2004.03.018", "volume": "23", "author": "D Rosenthal", "year": "2004", "unstructured": "Rosenthal D, Chrisant MR, Edens E, Mahony L, Canter C, Colan S, Dubin A, Lamour J, Ross R, Shaddy R, et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004;23:1313\u201333.", "journal-title": "J Heart Lung Transplant"}, {"key": "9_CR342", "doi-asserted-by": "crossref", "first-page": "1429", "DOI": "10.1056/NEJM198706043162301", "volume": "316", "author": "The CONSENSUS Trial Study Group", "year": "1987", "unstructured": "The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429\u201335.", "journal-title": "N Engl J Med"}, {"key": "9_CR343", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1056/NEJM199108013250501", "volume": "325", "author": "The SOLVD Investigators", "year": "1991", "unstructured": "The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293\u2013302.", "journal-title": "N Engl J Med"}, {"key": "9_CR344", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1056/NEJM199209033271003", "volume": "327", "author": "The SOLVD Investigators", "year": "1992", "unstructured": "The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:685\u201391.", "journal-title": "N Engl J Med"}, {"key": "9_CR345", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1056/NEJM199108013250502", "volume": "325", "author": "JN Cohn", "year": "1991", "unstructured": "Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303\u201310.", "journal-title": "N Engl J Med"}, {"key": "9_CR346", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1056/NEJMoa010713", "volume": "345", "author": "JN Cohn", "year": "2001", "unstructured": "Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667\u201375.", "journal-title": "N Engl J Med"}, {"key": "9_CR347", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1161/01.CIR.99.8.990", "volume": "99", "author": "G Hamroff", "year": "1999", "unstructured": "Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, Jondeau G, Olivari MT, Thomas S, Le Jemtel TH. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999;99:990\u20132.", "journal-title": "Circulation"}, {"key": "9_CR348", "doi-asserted-by": "crossref", "first-page": "1056", "DOI": "10.1161/01.CIR.100.10.1056", "volume": "100", "author": "RS McKelvie", "year": "1999", "unstructured": "McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 1999;100:1056\u201364.", "journal-title": "Circulation"}, {"key": "9_CR349", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1016/S0140-6736(03)14282-1", "volume": "362", "author": "MA Pfeffer", "year": "2003", "unstructured": "Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet. 2003;362:759\u201366.", "journal-title": "Lancet"}, {"key": "9_CR350", "doi-asserted-by": "crossref", "first-page": "1603", "DOI": "10.1016/j.jacc.2005.11.069", "volume": "47", "author": "JG Cleland", "year": "2006", "unstructured": "Cleland JG, Charlesworth A, Lubsen J, Swedberg K, Remme WJ, Erhardt L, Di Lenarda A, Komajda M, Metra M, Torp-Pedersen C, et al. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the \u201cpatient journey\u201d) in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). J Am Coll Cardiol. 2006;47:1603\u201311.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR351", "doi-asserted-by": "crossref", "first-page": "1349", "DOI": "10.1056/NEJM199605233342101", "volume": "334", "author": "M Packer", "year": "1996", "unstructured": "Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349\u201355.", "journal-title": "N Engl J Med"}, {"key": "9_CR352", "doi-asserted-by": "crossref", "first-page": "1651", "DOI": "10.1056/NEJM200105313442201", "volume": "344", "author": "M Packer", "year": "2001", "unstructured": "Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651\u20138.", "journal-title": "N Engl J Med"}, {"key": "9_CR353", "unstructured": "Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 353:2001\u20137.", "DOI": "10.1016/S0140-6736(99)04440-2", "doi-asserted-by": "crossref"}, {"key": "9_CR354", "unstructured": "The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999; 353:9\u201313.", "DOI": "10.1016/S0140-6736(98)11181-9", "doi-asserted-by": "crossref"}, {"key": "9_CR355", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1056/NEJM199307013290101", "volume": "329", "author": "M Packer", "year": "1993", "unstructured": "Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med. 1993;329:1\u20137.", "journal-title": "N Engl J Med"}, {"key": "9_CR356", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1001/jama.289.7.871", "volume": "289", "author": "SS Rathore", "year": "2003", "unstructured": "Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871\u20138.", "journal-title": "JAMA"}, {"issue": "2", "key": "9_CR357", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.4103/0974-2069.58317", "volume": "2", "author": "S Jain", "year": "2009", "unstructured": "Jain S, Vaidyanathan B. Digoxin in management of heart failure in children: should it be continued or relegated to the history books? Ann Pediatr Cardiol. 2009;2(2):149\u201352.", "journal-title": "Ann Pediatr Cardiol"}, {"key": "9_CR358", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1016/S0140-6736(10)61198-1", "volume": "376", "author": "K Swedberg", "year": "2010", "unstructured": "Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L on behalf of the SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875\u201385.", "journal-title": "Lancet"}, {"key": "9_CR359", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1056/NEJMoa1409077", "volume": "371", "author": "JJV McMurray", "year": "2014", "unstructured": "McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedburg K, Zile MR, PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.", "journal-title": "N Engl J Med"}, {"key": "9_CR360", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1054/jcaf.2002.31907", "volume": "8", "author": "RA Sirajuddin", "year": "2002", "unstructured": "Sirajuddin RA, Miller AB, Geraci SA. Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review. J Card Fail. 2002;8:48\u201353.", "journal-title": "J Card Fail"}, {"key": "9_CR361", "doi-asserted-by": "crossref", "first-page": "1616", "DOI": "10.1161/CIRCULATIONAHA.108.801753", "volume": "119", "author": "BM Massie", "year": "2009", "unstructured": "Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JGF, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR for the WATCH Trial Investigators. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure. Circulation. 2009;119:1616\u201324.", "journal-title": "Circulation"}, {"issue": "4", "key": "9_CR362", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1016/S0735-1097(98)00003-5", "volume": "31", "author": "L Koniaris", "year": "1998", "unstructured": "Koniaris L, Goldhaber S. Anticoagulation in dilated cardiomyopathy. JACC. 1998;31(4):745.", "journal-title": "JACC"}, {"key": "9_CR363", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1056/NEJMoa043399", "volume": "352", "author": "GH Bardy", "year": "2005", "unstructured": "Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225\u201337.", "journal-title": "N Engl J Med"}, {"key": "9_CR364", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1056/NEJMoa1608029", "volume": "375", "author": "L Kober", "year": "2016", "unstructured": "Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjaer H, Brandes A, Thogersen AM, Gustafsson F, Egstrup K, Videbaek R, Hassager C, Svendsen JH, Hofsten DE, Torp-Pedersen C, Pehrson S for the DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221\u201330.", "journal-title": "N Engl J Med"}, {"key": "9_CR365", "doi-asserted-by": "crossref", "first-page": "2D", "DOI": "10.1016/S0002-9149(02)03373-8", "volume": "91", "author": "WH Maisel", "year": "2003", "unstructured": "Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2D\u20138D.", "journal-title": "Am J Cardiol"}, {"issue": "3\u20134", "key": "9_CR366", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.3121/cmr.2010.908", "volume": "8", "author": "A Aleksova", "year": "2010", "unstructured": "Aleksova A, Merlo M, Zecchin M, Sabbadini G, Barbati G, Vitrella G, Di Lenarda A, Sinagra G. Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the heart muscle disease registry of trieste. Clin Med Res. 2010;8(3\u20134):142\u20139.", "journal-title": "Clin Med Res"}, {"key": "9_CR367", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1016/S0022-5223(99)70333-8", "volume": "117", "author": "BW Duncan", "year": "1999", "unstructured": "Duncan BW, Hraska V, Jonas RA, Wessel DL, Del Nido PJ, Laussen PC, Mayer JE, Lapierre RA, Wilson JM. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg. 1999;117:529\u201342.", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "9_CR368", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1016/S0003-4975(98)00914-X", "volume": "66", "author": "R Hetzer", "year": "1998", "unstructured": "Hetzer R, Loebe M, Potapov EV, Weng Y, Stiller B, Hennig E, exi-Meskishvili V, Lange PE. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg. 1998;66:1498\u2013506.", "journal-title": "Ann Thorac Surg"}, {"key": "9_CR369", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1016/S1053-2498(02)00386-8", "volume": "21", "author": "D Levi", "year": "2002", "unstructured": "Levi D, Marelli D, Plunkett M, Alejos J, Bresson J, Tran J, Eisenring C, Sadeghi A, Galindo A, Fazio D, et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant. 2002;21:760\u201370.", "journal-title": "J Heart Lung Transplant"}, {"key": "9_CR370", "doi-asserted-by": "crossref", "first-page": "1781", "DOI": "10.1016/j.jtcvs.2003.07.029", "volume": "126", "author": "AM McMahon", "year": "2003", "unstructured": "McMahon AM, van DC, Burch M, Whitmore P, Neligan S, Rees P, Radley-Smith R, Goldman A, Brown K, Cohen G, et al. Improved early outcome for end-stage dilated cardiomyopathy in children. J Thorac Cardiovasc Surg. 2003;126:1781\u20137.", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "9_CR371", "doi-asserted-by": "crossref", "first-page": "2993", "DOI": "10.1161/01.CIR.99.23.2993", "volume": "99", "author": "A Auricchio", "year": "1999", "unstructured": "Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999;99:2993\u20133001.", "journal-title": "Circulation"}, {"key": "9_CR372", "doi-asserted-by": "crossref", "first-page": "2140", "DOI": "10.1056/NEJMoa032423", "volume": "350", "author": "MR Bristow", "year": "2004", "unstructured": "Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140\u201350.", "journal-title": "N Engl J Med"}, {"key": "9_CR373", "doi-asserted-by": "crossref", "first-page": "1539", "DOI": "10.1056/NEJMoa050496", "volume": "352", "author": "JG Cleland", "year": "2005", "unstructured": "Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539\u201349.", "journal-title": "N Engl J Med"}, {"key": "9_CR374", "doi-asserted-by": "crossref", "first-page": "1928", "DOI": "10.1093/eurheartj/ehl099", "volume": "27", "author": "JG Cleland", "year": "2006", "unstructured": "Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928\u201332.", "journal-title": "Eur Heart J"}, {"issue": "3", "key": "9_CR375", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1016/j.hrthm.2010.11.013", "volume": "8", "author": "CJ McLeod", "year": "2011", "unstructured": "McLeod CJ, Shen WK, Rea RF, Friedman PA, Hayes DL, Wokhlu A, Webster TL, Wiste HJ, Hodge DO, Bradley DJ, Hammill SC, Packer DL, Cha YM. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. Heart Rhythm. 2011;8(3):377\u201382.", "journal-title": "Heart Rhythm"}, {"key": "9_CR376", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1056/NEJM199701233360407", "volume": "336", "author": "SS Kushwaha", "year": "1997", "unstructured": "Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997;336:267\u201376.", "journal-title": "N Engl J Med"}, {"key": "9_CR377", "author": "SW Denfield", "first-page": "264", "year": "2006", "unstructured": "Denfield SW. Restrictive cardiomyopathy and constrictive pericarditis. In: Chang AC, Towbin JA, editors. Heart failure in children and young adults: from molecular mechanisms to medical and surgical strategies. Philadelphia: Saunders Elsevier; 2006. p. 264\u201377.", "volume-title": "Heart failure in children and young adults: from molecular mechanisms to medical and surgical strategies"}, {"key": "9_CR378", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1172/JCI200316336", "volume": "111", "author": "J Mogensen", "year": "2003", "unstructured": "Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest. 2003;111:209\u201316.", "journal-title": "J Clin Invest"}, {"key": "9_CR379", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1111/j.1399-0004.2008.01062.x", "volume": "74", "author": "S Menon", "year": "2008", "unstructured": "Menon S, Michels V, Pellikka P, Ballew J, Karst M, Herron K, Nelson S, Rodeheffer R, Olson T. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet. 2008;74:445\u201354.", "journal-title": "Clin Genet"}, {"issue": "25", "key": "9_CR380", "doi-asserted-by": "crossref", "first-page": "3021", "DOI": "10.1016/j.jacc.2016.04.024", "volume": "67", "author": "M Gallego-Delgado", "year": "2016", "unstructured": "Gallego-Delgado M, Delgado JF, Brossa-Loidi V, Palomo J, Marzoa-Rivas R, Perez-Villa F, Salazar-Mendiguchia J, Ruiz-Canop MJ, Gonzalez-Lopez E, Padron-Barthe L, Bornstein B, Alonso-Pulpon L, Garcia-Pavia P. Idiopathic restrictive cardiomyopathy is primarily a genetic disease. JACC. 2016;67(25):3021\u20133.", "journal-title": "JACC"}, {"key": "9_CR381", "doi-asserted-by": "crossref", "first-page": "e0163362", "DOI": "10.1371/journal.pone.0163362", "volume": "11", "author": "A Kostareva", "year": "2016", "unstructured": "Kostareva A, Kiselev A, Gudkova A, Frishman G, Ruepp A, Frishmana D, Smolina N, Tarnovskaya S, Nilsson D, Zlotina A, Khodyuchenko T, Vershinina T, Pervunina T, Klyushina A, Kozlenok A, Sjoberg G, Golovijova I, Sejersen T, Shlyakhto E. Genetic spectrum of idiopathic restrictive cardiomyopathy uncovered by next-generation sequencing. PLoS One. 2016;11:e0163362.", "journal-title": "PLoS One"}, {"key": "9_CR382", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1111/j.1747-0803.2008.00165.x", "volume": "3", "author": "S Karam", "year": "2008", "unstructured": "Karam S, Raboisson MJ, Ducreux C, Chalabreysse L, Millat G, Bozio A, Bouvagnet P. A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy. Congenit Heart Dis. 2008;3:138\u201343.", "journal-title": "Congenit Heart Dis"}, {"issue": "11", "key": "9_CR383", "doi-asserted-by": "crossref", "first-page": "1478", "DOI": "10.1136/hrt.2007.134684", "volume": "94", "author": "JP Kaski", "year": "2008", "unstructured": "Kaski JP, Syrris P, Tome Esteban MT, Fenton MJ, Christensen M, Andersen PS, Sebire N, Ashworth M, Deanfield JE, McKenna WJ, Elliott PM, et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart. 2008;94(11):1478\u201384.", "journal-title": "Heart"}, {"key": "9_CR384", "doi-asserted-by": "crossref", "first-page": "1830", "DOI": "10.1542/peds.2005-2301", "volume": "117", "author": "SB Peddy", "year": "2006", "unstructured": "Peddy SB, Vricella LA, Crosson JE, Oswald GL, Cohn RD, Cameron DE, Valle D, Loeys BL. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics. 2006;117:1830\u20133.", "journal-title": "Pediatrics"}, {"key": "9_CR385", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1056/NEJM200003163421104", "volume": "342", "author": "MC Dalakas", "year": "2000", "unstructured": "Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med. 2000;342:770\u201380.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "9_CR386", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1111/j.1540-8159.2004.00484.x", "volume": "27", "author": "LGC Luethje", "year": "2004", "unstructured": "Luethje LGC, Boennemann C, Goldfarb L, Goebel HH, Halle M. Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. PACE. 2004;27(4):559\u201360.", "journal-title": "PACE"}, {"key": "9_CR387", "doi-asserted-by": "crossref", "first-page": "30909", "DOI": "10.1074/jbc.M500287200", "volume": "280", "author": "AV Gomes", "year": "2005", "unstructured": "Gomes AV, Liang J, Potter JD. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem. 2005;280:30909\u201315.", "journal-title": "J Biol Chem"}, {"key": "9_CR388", "doi-asserted-by": "crossref", "first-page": "1519", "DOI": "10.1016/j.bbrc.2005.10.116", "volume": "338", "author": "F Yumoto", "year": "2005", "unstructured": "Yumoto F, Lu QW, Morimoto S, Tanaka H, Kono N, Nagata K, Ojima T, Takahashi-Yanaga F, Miwa Y, Sasaguri T, et al. Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun. 2005;338:1519\u201326.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR389", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1161/01.RES.87.9.805", "volume": "87", "author": "J James", "year": "2000", "unstructured": "James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000;87:805\u201311.", "journal-title": "Circ Res"}, {"key": "9_CR390", "doi-asserted-by": "crossref", "first-page": "2419", "DOI": "10.1016/j.jacc.2007.02.061", "volume": "49", "author": "T Kubo", "year": "2007", "unstructured": "Kubo T, Gimeno JR, Bahl A, Steffensen U, Steffensen M, Osman E, Thaman R, Mogensen J, Elliott PM, Doi Y, et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol. 2007;49:2419\u201326.", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR391", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1136/hrt.30.3.391", "volume": "30", "author": "AG Shaper", "year": "1968", "unstructured": "Shaper AG, Hutt MS, Coles RM. Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda 1950-1965. Br Heart J. 1968;30:391\u2013401.", "journal-title": "Br Heart J"}, {"key": "9_CR392", "doi-asserted-by": "crossref", "first-page": "1046", "DOI": "10.1016/S0002-9149(97)00601-2", "volume": "80", "author": "A Angelini", "year": "1997", "unstructured": "Angelini A, Calzolari V, Thiene G, Boffa GM, Valente M, Daliento L, Basso C, Calabrese F, Razzolini R, Livi U, et al. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol. 1997;80:1046\u201350.", "journal-title": "Am J Cardiol"}, {"key": "9_CR393", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1136/hrt.63.2.114", "volume": "63", "author": "AP Fitzpatrick", "year": "1990", "unstructured": "Fitzpatrick AP, Shapiro LM, Rickards AF, Poole-Wilson PA. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J. 1990;63:114\u20138.", "journal-title": "Br Heart J"}, {"key": "9_CR394", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1136/hrt.2004.049502", "volume": "92", "author": "MJ Fenton", "year": "2006", "unstructured": "Fenton MJ, Chubb H, McMahon AM, Rees P, Elliott MJ, Burch M. Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart (British Cardiac Society). 2006;92:85\u20139.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR395", "doi-asserted-by": "crossref", "first-page": "1199", "DOI": "10.1136/hrt.2004.043869", "volume": "91", "author": "LM Russo", "year": "2005", "unstructured": "Russo LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart (British Cardiac Society). 2005;91:1199\u2013202.", "journal-title": "Heart (British Cardiac Society)"}, {"key": "9_CR396", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1093/oxfordjournals.eurheartj.a015076", "volume": "17", "author": "M Gewillig", "year": "1996", "unstructured": "Gewillig M, Mertens L, Moerman P, Dumoulin M. Idiopathic restrictive cardiomyopathy in childhood. A diastolic disorder characterized by delayed relaxation. Eur Heart J. 1996;17:1413\u201320.", "journal-title": "Eur Heart J"}, {"key": "9_CR397", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1161/01.CIR.102.8.876", "volume": "102", "author": "SM Rivenes", "year": "2000", "unstructured": "Rivenes SM, Kearney DL, Smith EOB, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation. 2000;102:876\u201382.", "journal-title": "Circulation"}, {"key": "9_CR398", "doi-asserted-by": "crossref", "first-page": "1805", "DOI": "10.1001/archinte.166.17.1805", "volume": "166", "author": "KB Shah", "year": "2006", "unstructured": "Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006;166:1805\u201313.", "journal-title": "Arch Intern Med"}, {"key": "9_CR399", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/S1053-2498(00)00162-5", "volume": "20", "author": "Sc Chen", "year": "2001", "unstructured": "Chen Sc, Balfour IC, Jureidini S. Clinical spectrum of restrictive cardiomyopathy in children. J Heart Lung Transplant. 2001;20:90\u20132.", "journal-title": "J Heart Lung Transplant"}, {"key": "9_CR400", "first-page": "38", "volume": "24", "author": "SW Denfield", "year": "1997", "unstructured": "Denfield SW, Rosenthal G, Gajarski RJ, Bricker JT, Schowengerdt KO, Price JK, Towbin JA. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J. 1997;24:38\u201344.", "journal-title": "Tex Heart Inst J"}, {"key": "9_CR401", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/S0002-9149(02)02522-5", "volume": "90", "author": "RJ Weller", "year": "2002", "unstructured": "Weller RJ, Weintraub R, Addonizio LJ, Chrisant MR, Gersony WM, Hsu DT. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol. 2002;90:501\u20136.", "journal-title": "Am J Cardiol"}, {"key": "9_CR402", "doi-asserted-by": "crossref", "first-page": "1589", "DOI": "10.1016/0002-8703(92)90814-C", "volume": "123", "author": "AB Lewis", "year": "1992", "unstructured": "Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J. 1992;123:1589\u201393.", "journal-title": "Am Heart J"}, {"key": "9_CR403", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/S1053-2498(01)00400-4", "volume": "21", "author": "MT Kimberling", "year": "2002", "unstructured": "Kimberling MT, Balzer DT, Hirsch R, Mendeloff E, Huddleston CB, Canter CE. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant. 2002;21:455\u20139.", "journal-title": "J Heart Lung Transplant"}, {"key": "9_CR404", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1161/01.CIR.83.2.523", "volume": "83", "author": "AR Bengur", "year": "1991", "unstructured": "Bengur AR, Beekman RH, Rocchini AP, Crowley DC, Schork MA, Rosenthal A. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation. 1991;83:523\u20137.", "journal-title": "Circulation"}], "container-title": ["Cardiovascular Genetics and Genomics"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-66114-8_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T13:09:43Z", "timestamp": 1570626583000}, "score": 25.893778, "issued": {"date-parts": [[2018]]}, "ISBN": ["9783319661124", "9783319661148"], "references-count": 404, "URL": "http://dx.doi.org/10.1007/978-3-319-66114-8_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T02:30:24Z", "timestamp": 1576809024166}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780198784906", "type": "print"}, {"value": "9780191827143", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 12]]}, "abstract": "<p>Cardiomyopathy in childhood is a rare and heterogeneous disease. The true prevalence is unknown; however, epidemiological studies from the United States, Australia, and Finland have reported an annual incidence of between 0.65 and 12.4 per 100,000. The most common type of cardiomyopathy in childhood is dilated cardiomyopathy followed by hypertrophic cardiomyopathy, while restrictive cardiomyopathy and other forms are much rarer (58.6% vs 25.5% vs 2.5% respectively). Although children may present at any age, the majority present under 1 year of age (63.4%).</p>", "DOI": "10.1093/med/9780198784906.003.0799", "type": "book-chapter", "created": {"date-parts": [[2018, 8, 18]], "date-time": "2018-08-18T16:50:20Z", "timestamp": 1534611020000}, "page": "1554-1560", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Childhood cardiomyopathy"], "prefix": "10.1093", "author": [{"given": "Juan", "family": "Kaski", "sequence": "first", "affiliation": []}, {"given": "Gabrielle", "family": "Norrish", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2018, 7]]}, "container-title": ["ESC CardioMed"], "original-title": ["Childhood cardiomyopathy"], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:08:22Z", "timestamp": 1574870902000}, "score": 25.466515, "issued": {"date-parts": [[2018, 7]]}, "ISBN": ["9780198784906", "9780191827143"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780198784906.003.0799"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:59:14Z", "timestamp": 1574287154483}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Paediatrics and Child Health"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1016/j.paed.2006.12.001", "type": "journal-article", "created": {"date-parts": [[2007, 4, 10]], "date-time": "2007-04-10T19:06:17Z", "timestamp": 1176231977000}, "page": "19-24", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Hypertrophic cardiomyopathy in children"], "prefix": "10.1016", "volume": "17", "author": [{"given": "M Teresa", "family": "Tome Esteban", "sequence": "first", "affiliation": []}, {"given": "Juan P", "family": "Kaski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Paediatrics and Child Health"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1751722206001855?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1751722206001855?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 8]], "date-time": "2019-01-08T09:57:31Z", "timestamp": 1546941451000}, "score": 24.7048, "issued": {"date-parts": [[2007, 1]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2007, 1]]}, "issue": "1"}, "alternative-id": ["S1751722206001855"], "URL": "http://dx.doi.org/10.1016/j.paed.2006.12.001", "ISSN": ["1751-7222"], "issn-type": [{"value": "1751-7222", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:39:14Z", "timestamp": 1574476754958}, "reference-count": 0, "publisher": "BMJ", "issue": "14", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Heart"], "published-print": {"date-parts": [[2012, 7, 15]]}, "DOI": "10.1136/heartjnl-2011-300531", "type": "journal-article", "created": {"date-parts": [[2012, 5, 17]], "date-time": "2012-05-17T17:08:19Z", "timestamp": 1337274499000}, "page": "1044-1054", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Hypertrophic cardiomyopathy in children"], "prefix": "10.1136", "volume": "98", "author": [{"given": "Jeffrey P", "family": "Moak", "sequence": "first", "affiliation": []}, {"given": "Juan Pablo", "family": "Kaski", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2012, 5, 16]]}, "container-title": ["Heart"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/heartjnl-2011-300531", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T21:06:21Z", "timestamp": 1482527181000}, "score": 24.7048, "issued": {"date-parts": [[2012, 5, 16]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 6, 27]]}, "published-print": {"date-parts": [[2012, 7, 15]]}, "issue": "14"}, "alternative-id": ["10.1136/heartjnl-2011-300531"], "URL": "http://dx.doi.org/10.1136/heartjnl-2011-300531", "ISSN": ["1355-6037", "1468-201X"], "issn-type": [{"value": "1355-6037", "type": "print"}, {"value": "1468-201X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T23:29:44Z", "timestamp": 1575242984327}, "reference-count": 0, "publisher": "BMJ Publishing Group Ltd and British Cardiovascular Society", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 2]]}, "DOI": "10.1136/heartjnl-2017-bcca.4", "type": "proceedings-article", "created": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T09:48:11Z", "timestamp": 1518083291000}, "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["4\u2005Clinical features and outcomes of childhood hypertrophic cardiomyopathy: a retrospective study in the united kingdom"], "prefix": "10.1136", "author": [{"given": "G", "family": "Norrish", "sequence": "first", "affiliation": []}, {"given": "E", "family": "Field", "sequence": "additional", "affiliation": []}, {"given": "JP", "family": "Kaski", "sequence": "additional", "affiliation": []}, {"name": "International Paediatric Hypertrophic Cardiomyopathy Consortium", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2018, 2, 2]]}, "event": {"name": "British Congenital Cardiac Association, Annual meeting abstracts 9\u201310 November 2017, Great Ormond Street Institute of Child Health, London, UK"}, "container-title": ["Oral presentations"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/heartjnl-2017-BCCA.4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 2, 22]], "date-time": "2018-02-22T12:05:17Z", "timestamp": 1519301117000}, "score": 23.962507, "issued": {"date-parts": [[2018, 2]]}, "references-count": 0, "alternative-id": ["10.1136/heartjnl-2017-BCCA.4"], "URL": "http://dx.doi.org/10.1136/heartjnl-2017-bcca.4"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:21:19Z", "timestamp": 1574486479098}, "reference-count": 32, "publisher": "Elsevier", "isbn-type": [{"value": "9780702034268", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1016/b978-0-7020-3426-8.00057-5", "type": "book-chapter", "created": {"date-parts": [[2010, 12, 28]], "date-time": "2010-12-28T09:14:48Z", "timestamp": 1293527688000}, "page": "425-429", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Hypertrophic Cardiomyopathy"], "prefix": "10.1016", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Diagnosis and Management of Adult Congenital Heart Disease"], "deposited": {"date-parts": [[2018, 12, 6]], "date-time": "2018-12-06T01:52:43Z", "timestamp": 1544061163000}, "score": 22.652927, "issued": {"date-parts": [[2011]]}, "ISBN": ["9780702034268"], "references-count": 32, "URL": "http://dx.doi.org/10.1016/b978-0-7020-3426-8.00057-5"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:13:32Z", "timestamp": 1574525612358}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199557462", "type": "print"}, {"value": "9780191753312", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010, 11]]}, "abstract": "<p>\n\n</p>\n               <p>Introduction <italic>298</italic>\n               </p>\n               <p>\n</p>\n               <p>Table 10.1 Cardiac manifestations of inborn errors of metabolism <italic>299</italic>\n               </p>\n               <p>Inherited metabolic disorders cause heart disease through the accumulation or infiltration of abnormal metabolic products. They generally cause diastolic impairment, with different degrees of systolic impairment and arrhythmias. The particular importance of these conditions is that some cases can be treated with enzyme-replacement therapy....</p>", "DOI": "10.1093/med/9780199557462.003.0122", "type": "book-chapter", "created": {"date-parts": [[2013, 1, 4]], "date-time": "2013-01-04T16:52:00Z", "timestamp": 1357318320000}, "page": "297-306", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cardiac manifestations of inborn errors of metabolism and infiltrative cardiac disease"], "prefix": "10.1093", "author": [{"given": "Juan Carlos", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2012, 11]]}, "container-title": ["Drugs in Cardiology"], "original-title": ["Cardiac manifestations of inborn errors of metabolism and infiltrative cardiac disease"], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T09:59:18Z", "timestamp": 1559210358000}, "score": 21.953897, "issued": {"date-parts": [[2010, 11]]}, "ISBN": ["9780199557462", "9780191753312"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199557462.003.0122"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T10:45:29Z", "timestamp": 1575456329729}, "reference-count": 0, "publisher": "PAGEPress Publications", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/4.0", "start": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T00:00:00Z", "timestamp": 1556064000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cardiogenetics"], "abstract": "<jats:p>Not available</jats:p>", "DOI": "10.4081/cardiogenetics.2019.8048", "type": "journal-article", "created": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T15:29:47Z", "timestamp": 1557847787000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Response to Skinner: Risk stratification in hypertrophic cardiomyopathy: Time to think about the electrocardiogram"], "prefix": "10.4081", "volume": "9", "author": [{"given": "Juan Pablo", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "2549", "published-online": {"date-parts": [[2019, 4, 24]]}, "container-title": ["Cardiogenetics"], "link": [{"URL": "https://www.pagepressjournals.com/index.php/cardiogen/article/download/8048/8048", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.pagepressjournals.com/index.php/cardiogen/article/download/8048/8048", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T15:29:48Z", "timestamp": 1557847788000}, "score": 21.727974, "issued": {"date-parts": [[2019, 4, 24]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2019, 4, 19]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4081/cardiogenetics.2019.8048", "ISSN": ["2035-8148", "2035-8253"], "issn-type": [{"value": "2035-8253", "type": "print"}, {"value": "2035-8148", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:14:00Z", "timestamp": 1574309640882}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 1, 1]], "date-time": "2009-01-01T00:00:00Z", "timestamp": 1230768000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Heart, Lung and Circulation"], "published-print": {"date-parts": [[2009]]}, "DOI": "10.1016/j.hlc.2009.04.056", "type": "journal-article", "created": {"date-parts": [[2009, 7, 4]], "date-time": "2009-07-04T08:39:37Z", "timestamp": 1246696777000}, "page": "S24", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Viability Assessment Using Cardiac MRI is an Important Factor in The Decision to Revascularise Patients with Ischaemic Cardiomyopathy"], "prefix": "10.1016", "volume": "18", "author": [{"given": "D", "family": "Oh", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "JP", "family": "Christiansen", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Heart, Lung and Circulation"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1443950609002248?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1443950609002248?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 18]], "date-time": "2018-12-18T15:27:21Z", "timestamp": 1545146841000}, "score": 21.727327, "issued": {"date-parts": [[2009]]}, "references-count": 0, "alternative-id": ["S1443950609002248"], "URL": "http://dx.doi.org/10.1016/j.hlc.2009.04.056", "ISSN": ["1443-9506"], "issn-type": [{"value": "1443-9506", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:22:14Z", "timestamp": 1575058934572}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 2, 15]]}, "DOI": "10.1016/s0008-6363(01)00460-6", "type": "journal-article", "created": {"date-parts": [[2002, 10, 10]], "date-time": "2002-10-10T18:17:37Z", "timestamp": 1034273857000}, "page": "620-626", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Overview of gender aspects of cardiac syndrome X"], "prefix": "10.1093", "volume": "53", "author": [{"given": "J", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Cardiovascular Research"], "link": [{"URL": "http://academic.oup.com/cardiovascres/article-pdf/53/3/620/933392/53-3-620.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T20:04:30Z", "timestamp": 1503432270000}, "score": 21.72203, "issued": {"date-parts": [[2002, 2, 15]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "alternative-id": ["S0008-6363(01)00460-6"], "URL": "http://dx.doi.org/10.1016/s0008-6363(01)00460-6", "ISSN": ["0008-6363"], "issn-type": [{"value": "0008-6363", "type": "print"}], "subject": ["Physiology (medical)", "Physiology", "Cardiology and Cardiovascular Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T16:09:35Z", "timestamp": 1574784575314}, "reference-count": 39, "publisher": "Elsevier", "isbn-type": [{"value": "9780702069291", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1016/b978-0-7020-6929-1.00061-7", "type": "book-chapter", "created": {"date-parts": [[2017, 5, 20]], "date-time": "2017-05-20T19:25:38Z", "timestamp": 1495308338000}, "page": "615-621", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Hypertrophic Cardiomyopathy"], "prefix": "10.1016", "author": [{"given": "Gabrielle", "family": "Norrish", "sequence": "first", "affiliation": []}, {"given": "Juan Pablo", "family": "Kaski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Diagnosis and Management of Adult Congenital Heart Disease"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780702069291000617?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780702069291000617?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T16:23:20Z", "timestamp": 1535819000000}, "score": 21.658455, "issued": {"date-parts": [[2018]]}, "ISBN": ["9780702069291"], "references-count": 39, "URL": "http://dx.doi.org/10.1016/b978-0-7020-6929-1.00061-7"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:34:27Z", "timestamp": 1574728467838}, "reference-count": 54, "publisher": "Cambridge University Press (CUP)", "issue": "S2", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2015, 9, 17]], "date-time": "2015-09-17T00:00:00Z", "timestamp": 1442448000000}, "delay-in-days": 47, "content-version": "unspecified"}], "content-domain": {"domain": ["journals.cambridge.org"], "crossmark-restriction": true}, "short-container-title": ["Cardiol Young"], "published-print": {"date-parts": [[2015, 8]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>There has been a progressive evolution in systems of classification for cardiomyopathy, driven by advances in imaging modalities, disease recognition, and genetics, following initial clinical descriptions in the 1960s. A pathophysiological classification emerged and was endorsed by World Health Organisation Task Forces in 1980 and 1995: dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathies; subdivided into idiopathic and disease-specific cardiomyopathies. Genetic advances have increasingly linked \u201cidiopathic\u201d phenotypes to specific mutations, although most linkages exhibit highly variable or little genotype\u2013phenotype correlation, confounded by age-dependent changes and varying penetrance. The following two dominant classification systems are currently in use, with advocates in both continents. First, American Heart Association (2006): \u201cA heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilatation due to a variety of causes that frequently are genetic\u201d. These are subdivided to those predominantly involving the heart \u2013 primary \u2013 due to genetic mutation, including ion channelopathies, acquired disease, or mixed; and those with systemic involvement in other organ systems \u2013 secondary. Second, European Society of Cardiology (2008): \u201cA myocardial disorder in which heart muscle is structurally and functionally abnormal\u2026 sufficient to cause the observed myocardial abnormality\u201d, with subdivision to familial and non-familial, excluding ion channelopathies, and split to specific disease subtypes and idiopathic. Further differences exist in the definitions for hypertrophic cardiomyopathy; however, whichever high-level classification is used, the clinical reality remains phenotype driven. Clinical evaluation and diagnostic imaging dominate initial patient contact, revealing diagnostic red flags that determine further specific tests. Genetic testing is undertaken early. A recent attempt to harmonise these competing systems named the MOGE(S) system, based on descriptive logical nosology, currently remains unproven as a fully practical solution.</jats:p>", "DOI": "10.1017/s1047951115001201", "type": "journal-article", "created": {"date-parts": [[2015, 9, 17]], "date-time": "2015-09-17T09:13:45Z", "timestamp": 1442481225000}, "page": "31-42", "update-policy": "http://dx.doi.org/10.1017/policypage", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Nomenclature and systems of classification for cardiomyopathy in children"], "prefix": "10.1017", "volume": "25", "author": [{"given": "Laura", "family": "Konta", "sequence": "first", "affiliation": []}, {"given": "Rodney C. G.", "family": "Franklin", "sequence": "additional", "affiliation": []}, {"given": "Juan P.", "family": "Kaski", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2015, 9, 17]]}, "reference": [{"key": "S1047951115001201_ref28", "DOI": "10.1093/eurjhf/hfr167", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref4", "DOI": "10.1093/eurheartj/ehm342", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref43", "DOI": "10.1161/hc5001.100834", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref20", "DOI": "10.1172/JCI62862", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref24", "DOI": "10.1016/j.jacc.2009.02.050", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref25", "author": "Abdullah", "first-page": "699", "year": "1999", "article-title": "Dilated cardiomyopathy as a first sign of nutritional vitamin D deficiency rickets in infancy", "journal-title": "Can J Cardiol"}, {"key": "S1047951115001201_ref3", "DOI": "10.1161/01.CIR.93.5.841", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref27", "DOI": "10.1179/146532808X335688", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref40", "DOI": "10.1016/j.hfc.2012.12.012", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref49", "DOI": "10.1161/CIRCGENETICS.108.835645", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref13", "DOI": "10.1007/s00246-003-0538-8", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref30", "first-page": "310", "article-title": "Hypoparathyroidism and heart failure in thalassemic patients: a case report", "volume": "2 (Suppl 2)", "author": "Tsironi", "year": "2004", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "S1047951115001201_ref52", "DOI": "10.1093/eurheartj/ehr260", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref36", "DOI": "10.1161/CIRCULATIONAHA.106.660241", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref15", "DOI": "10.1161/CIRCULATIONAHA.106.613562", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref41", "DOI": "10.1161/CIRCULATIONAHA.106.174287", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref5", "DOI": "10.1136/heartjnl-2012-301995", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref31", "DOI": "10.1111/j.1540-8159.2009.02383.x", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref48", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1161/CIRCGENETICS.108.788703", "article-title": "How should hypertrophic cardiomyopathy be classified?", "volume": "2", "author": "Maon", "year": "2009", "journal-title": "Circ Cardiovasc Genet"}, {"key": "S1047951115001201_ref19", "DOI": "10.1016/j.jacc.2011.01.015", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref10", "DOI": "10.1016/0167-5273(89)90193-9", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref50", "DOI": "10.1093/eurheartj/ehs397", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref12", "DOI": "10.1007/s00246-002-0251-z", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref1", "DOI": "10.1016/S0140-6736(57)90159-9", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref53", "DOI": "10.1016/j.jacc.2011.08.078", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref21", "DOI": "10.1016/j.jacc.2011.09.074", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref32", "DOI": "10.1016/j.ijcard.2006.05.019", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref14", "DOI": "10.1097/00000441-200104000-00003", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref45", "DOI": "10.1161/CIRCULATIONAHA.105.592899", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref37", "first-page": "18", "article-title": "Is arrhythmogenic right ventricular cardiomyopathy a paediatric problem too?", "volume": "3", "author": "Turrini", "year": "2001", "journal-title": "Images Paediatr Cardiol"}, {"key": "S1047951115001201_ref54", "DOI": "10.1161/01.CIR.0000100664.10777.B8", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref8", "DOI": "10.1161/01.CIR.58.3.402", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref33", "DOI": "10.1136/hrt.2007.134684", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref16", "DOI": "10.1016/j.ppedcard.2007.11.006", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref35", "DOI": "10.1161/CIRCULATIONAHA.108.840827", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref11", "DOI": "10.1136/heartjnl-2011-300531", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref47", "first-page": "2733", "article-title": "ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy", "volume": "35", "author": "Elliott", "year": "2014", "journal-title": "Eur Heart J"}, {"key": "S1047951115001201_ref22", "DOI": "10.1161/01.CIR.89.1.252", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref46", "DOI": "10.1016/j.jacc.2014.05.027", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref38", "DOI": "10.1016/j.hrthm.2011.06.026", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref6", "DOI": "10.1161/01.CIR.92.4.785", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref29", "DOI": "10.1378/chest.79.2.225", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref18", "DOI": "10.1016/j.jacc.2004.11.066", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref9", "DOI": "10.1016/S0002-9149(83)80034-4", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref2", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.1136/hrt.44.6.672", "article-title": "Report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies", "volume": "44", "author": "Oakley", "year": "1980", "journal-title": "Br Heart J"}, {"key": "S1047951115001201_ref7", "DOI": "10.1016/j.hfc.2010.05.002", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref23", "DOI": "10.1016/j.pcad.2006.10.002", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref17", "DOI": "10.1136/hrt.77.6.549", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref39", "DOI": "10.1016/j.hrtlng.2006.12.003", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref42", "first-page": "197", "article-title": "Genetic basis and pathogenesis of Familial WPW Syndrome", "volume": "3", "author": "Sidhu", "year": "2003", "journal-title": "Indian Pacing Electrophysiol J"}, {"key": "S1047951115001201_ref44", "DOI": "10.1111/j.1540-8167.2006.00349.x", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref51", "DOI": "10.1093/eurheartj/ehr092", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref26", "DOI": "10.1007/s00246-002-0251-z", "doi-asserted-by": "publisher"}, {"key": "S1047951115001201_ref34", "DOI": "10.1155/2010/350706", "doi-asserted-by": "publisher"}], "container-title": ["Cardiology in the Young"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1047951115001201", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T21:47:10Z", "timestamp": 1555796830000}, "score": 21.146826, "issued": {"date-parts": [[2015, 8]]}, "references-count": 54, "journal-issue": {"published-print": {"date-parts": [[2015, 8]]}, "issue": "S2"}, "alternative-id": ["S1047951115001201"], "URL": "http://dx.doi.org/10.1017/s1047951115001201", "relation": {"cites": []}, "ISSN": ["1047-9511", "1467-1107"], "issn-type": [{"value": "1047-9511", "type": "print"}, {"value": "1467-1107", "type": "electronic"}], "assertion": [{"value": "\u00a9 Cambridge University Press 2015\u00a0", "name": "license", "label": "License", "group": {"name": "copyright_and_licensing", "label": "Copyright and Licensing"}}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:11:30Z", "timestamp": 1574115090928}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Heart Journal"], "published-print": {"date-parts": [[2001, 2, 15]]}, "DOI": "10.1053/euhj.2000.2152", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T13:54:50Z", "timestamp": 1032443690000}, "page": "283-293", "source": "Crossref", "is-referenced-by-count": 46, "title": ["Therapeutic options for the management ofpatients with cardiac syndrome X"], "prefix": "10.1093", "volume": "22", "author": [{"given": "J", "family": "Kaski", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["European Heart Journal"], "language": "en", "link": [{"URL": "http://academic.oup.com/eurheartj/article-pdf/22/4/283/17884563/283.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T00:32:09Z", "timestamp": 1503448329000}, "score": 21.031872, "issued": {"date-parts": [[2001, 2, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 2, 15]]}, "issue": "4"}, "alternative-id": ["S0195-668X(00)92152-3"], "URL": "http://dx.doi.org/10.1053/euhj.2000.2152", "ISSN": ["0195-668X"], "issn-type": [{"value": "0195-668X", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}